Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription Articles published in AIDS Retrieve available abstracts of 483 articles: HTML format

Single Articles

November 2025
1. SEWACK AB, Manning MR, Blazkova J, Justement JS, et al
   Correlations among quantitative assays that measure the size of HIV reservoirs in people with HIV receiving antiretroviral therapy.
   AIDS. 2025;39:1982-1984.
   PubMed    
   
   
   
2. BENZEKRI NA, Sambou JF, Diedhiou Y, Sagna ML, et al
   Partnering with traditional healers to increase HIV testing in Senegal, West Africa.
   AIDS. 2025;39:1978-1981.
   PubMed     Abstract available
   
   
   
3. GHANOONI D, Heise MJ, Sassaman K, Glidden DV, et al
   Suboptimal ART adherence, undetectable urine tenofovir, and higher C-reactive protein values.
   AIDS. 2025;39:1975-1978.
   PubMed     Abstract available
   
   
   
4. VERA JH, Martinez E
   Reassuring evidence on statins and cognition in people with HIV.
   AIDS. 2025;39:1970-1971.
   PubMed    
   
   
   
5. MOSEHOLM E, Omland LH, Katzenstein TL, Pedersen G, et al
   Retention in care and viral suppression in pregnant/postpartum vs. nonpregnant/nonpostpartum women with HIV.
   AIDS. 2025;39:1936-1945.
   PubMed     Abstract available
   
   
   
6. MCHENRY MS, Masese ER, Kinyanjui D, Were E, et al
   Ethical considerations for research involving pregnant women with HIV and their children.
   AIDS. 2025;39:1866-1877.
   PubMed     Abstract available
   
   
   
7. SMITH MR, Cai R, Cote HCF
   Off target effects of HIV integrase strand transfer inhibitors in cell and animal models: a scoping review.
   AIDS. 2025;39:1849-1865.
   PubMed     Abstract available
   
   
   October 2025
8. CARR A, Mngqibisa R, Khaertynova I, Kumar PN, et al
   Efficacy and safety of doravirine/islatravir in heavily treatment-experienced participants living with HIV-1 from a randomized trial.
   AIDS. 2025 Oct 2. doi: 10.1097/QAD.0000000000004367.
   PubMed     Abstract available
   
   
   
9. GIULIANI M, Zaccarelli M, Stingone C, Gianserra L, et al
   The paradox of rising syphilis among MSM living with HIV amid declining HIV infections: a 33-year analysis.
   AIDS. 2025;39:1841-1844.
   PubMed     Abstract available
   
   
   
10. GROENEWALD P, Glass T, Kallis N, Holmgren C, et al
    Under-reporting of HIV and AIDS as an underlying cause of death in South Africa.
    AIDS. 2025;39:1839-1841.
    PubMed     Abstract available
    
    
    
11. SCHAEFER R, Lievense B, Day S, Donaldson L, et al
    Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention research.
    AIDS. 2025;39:1835-1838.
    PubMed    
    
    
    
12. LESKO CR, Marshall BDL
    The cost of defunding HIV surveillance systems in the United States.
    AIDS. 2025;39:1833-1834.
    PubMed    
    
    
    
13. VANCE DE, Layton S
    Posttraumatic stress disorder and Veterans with HIV: commentary on neurocognition, social cognition, and resilience.
    AIDS. 2025;39:1828-1830.
    PubMed    
    
    
    
14. MASENGA SK, Capeau J
    Myosteatosis in HIV: the adipose tissue connection.
    AIDS. 2025;39:1825-1827.
    PubMed    
    
    
    
15. ARENAS-PINTO A, Abrescia N, Abdel-Hameed EA
    Metabolic dysfunction-associated steatotic liver disease and liver fibrosis in people with HIV.
    AIDS. 2025;39:1822-1824.
    PubMed    
    
    
    
16. DAWOOD H
    The role of ECG in risk prediction for sudden cardiac and unexpected death in people with HIV.
    AIDS. 2025;39:1820-1821.
    PubMed    
    
    
    
17. VANCE DE, Lee J
    Social cognition abilities in people with HIV: the role of stigma and other factors.
    AIDS. 2025;39:1688-1698.
    PubMed     Abstract available
    
    
    September 2025
18. MOUCHERAUD C, Trujillo D, Wagner Z, Garland W, et al
    Preferences for HIV prevention conditional cash transfers among Black/African American and Latinx cisgender MSM in Los Angeles.
    AIDS. 2025 Sep 26. doi: 10.1097/QAD.0000000000004361.
    PubMed     Abstract available
    
    
    
19. ANDERSON K, Madlala HP, Nyemba DC, Dinkele R, et al
    Infectious morbidity among children HIV-exposed uninfected in South Africa: elevated risk in infancy but not thereafter.
    AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004358.
    PubMed     Abstract available
    
    
    
20. NIKOLOVA KA, Moller DL, Loft JA, Suarez-Zdunek MA, et al
    Association of Cytomegalovirus Immunoglobulin G Antibodies with Prevalent and De Novo Hypertension in People With HIV.
    AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004355.
    PubMed     Abstract available
    
    
    
21. FISHER MC, Scherzer R, Postalcioglu M, Chen TK, et al
    Associations of repeated measures of plasma biomarkers of kidney tubular health with longitudinal kidney function in people with HIV.
    AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004359.
    PubMed     Abstract available
    
    
    
22. MARTIN-CARMONA J, Corona-Mata D, Tellez F, Navarrete Lorite MN, et al
    Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis.
    AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004357.
    PubMed     Abstract available
    
    
    
23. VAN DEUZEN CM, Rijnders BJA, Bax HI, Rokx C, et al
    Cerebral toxoplasmosis in the twenty-first century: long-term clinical outcomes in a retrospective cohort study in the Netherlands.
    AIDS. 2025 Sep 23. doi: 10.1097/QAD.0000000000004356.
    PubMed     Abstract available
    
    
    
24. MILIC J, Calza S, Lazzarini L, Cocchi M, et al
    Prevalence and risk factors of cognitive frailty in people with HIV.
    AIDS. 2025 Sep 19. doi: 10.1097/QAD.0000000000004352.
    PubMed     Abstract available
    
    
    
25. DIETERICH DT, Brunet L, Hsu RK, Mounzer K, et al
    Tenofovir interruption among people with HIV and HBV: HBV monitoring and risk of HBV reactivation and hepatitis flare.
    AIDS. 2025 Sep 19. doi: 10.1097/QAD.0000000000004353.
    PubMed     Abstract available
    
    
    
26. STOLTZ TT, Jensen AMR, Roed AKH, Frikke-Schmidt R, et al
    Plasma levels of lipoprotein(a) in persons with HIV compared to the general population.
    AIDS. 2025 Sep 19. doi: 10.1097/QAD.0000000000004349.
    PubMed     Abstract available
    
    
    
27. STARKE SJ, He Z, Hollamby R, Moloantoa T, et al
    Advanced HIV disease and 30-day mortality among hospitalized adults with virally suppressed HIV in South Africa.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004336.
    PubMed     Abstract available
    
    
    
28. WEI L, Tao C, Huang X, Wang RC, et al
    High triglyceride-glucose index is associated with diabetes mellitus in people with HIV in Southwest China: a 13-year retrospective longitudinal cohort study.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004342.
    PubMed     Abstract available
    
    
    
29. NAIK V, Nekkalapudi A, Boopathy AV, Falkard B, et al
    Emergence of in vitro resistance to lenacapavir is similar across HIV-1 subtypes.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004334.
    PubMed     Abstract available
    
    
    
30. FILIP I
    High body mass and depression accelerate physical decline in people with HIV - can exercise reverse the clock?
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004347.
    PubMed    
    
    
    
31. SUKUMARAN L, Dominguez-Dominguez L, Hamzah L, Liu J, et al
    Intersecting social determinants of health, multimorbidity and quality of life in people of Black ethnicities with HIV in South London: a mixed-methods study.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004343.
    PubMed     Abstract available
    
    
    
32. NAVARRO-SOLER R, Martin-Torres J, Lagarde M, Bisbal O, et al
    Impact of antiretroviral regimens containing Integrase Inhibitors on achieving viral suppression at ultra-low levels compared to other ART strategies.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004340.
    PubMed     Abstract available
    
    
    
33. CHANDRA A, Alt J, Dastgheyb RM, Veenhuis RT, et al
    Associations between cerebrospinal fluid N-acetyl-aspartyl-glutamate (NAAG) and cognitive function in people with HIV.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004341.
    PubMed     Abstract available
    
    
    
34. COOLEY SA, Ferreiro A, Nelson B, Sukhum K, et al
    A randomized controlled trial to unveil the influence of an exercise intervention on brain integrity and gut microbiome structure in individuals with HIV.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004346.
    PubMed     Abstract available
    
    
    
35. LIU Q, Jin L, Qing Y, Rang Z, et al
    Endoplasmic reticulum stress-induced goblet cell apoptosis might contribute to intestinal barrier damage in asymptomatic people living with HIV.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004335.
    PubMed     Abstract available
    
    
    
36. WENG R, Kwon JA, Hammoud M, Clifton B, et al
    Evaluating the impact of COVID-19 on the HIV epidemic among men who have sex with men in Australia.
    AIDS. 2025 Sep 15. doi: 10.1097/QAD.0000000000004344.
    PubMed     Abstract available
    
    
    
37. ASUPHON O, Boonpattharatthiti K, Rattanachaisit N, Wangteeraprasert A, et al
    Comparing clinical outcomes of antibiotics for treating mycobacterium avium complex infection in adults with HIV: a systematic review and network meta-analysis.
    AIDS. 2025 Sep 15. doi: 10.1097/QAD.0000000000004345.
    PubMed     Abstract available
    
    
    
38. SOULIE C, Balde A, Fofana D, Charpentier C, et al
    No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people living with HIV.
    AIDS. 2025 Sep 8. doi: 10.1097/QAD.0000000000004339.
    PubMed     Abstract available
    
    
    
39. ANNEQUIN M, Mora M, van Huizen R, Faye A, et al
    Structural factors associated with viral suppression among transgender women living with HIV in France.
    AIDS. 2025 Sep 8. doi: 10.1097/QAD.0000000000004337.
    PubMed     Abstract available
    
    
    
40. PATEL N, Dulion B, Lazcano I, Shi Q, et al
    Antiretroviral-specific associations between bone hormonal changes and treatment induced weight gain.
    AIDS. 2025 Sep 4. doi: 10.1097/QAD.0000000000004330.
    PubMed     Abstract available
    
    
    
41. SATRE DD, Sarovar V, Levine T, Alexeeff S, et al
    The relationship of smoking and unhealthy alcohol use to HIV care retention and viral suppression: findings from a multi-site cohort study.
    AIDS. 2025 Sep 4. doi: 10.1097/QAD.0000000000004329.
    PubMed     Abstract available
    
    
    
42. DURSTENFELD MS, Nance RM, Jones R, Abelman R, et al
    Predicting risk of cardiovascular events (PREVENT) score accuracy among people with HIV in the multicenter CNICS cohort.
    AIDS. 2025 Sep 4. doi: 10.1097/QAD.0000000000004331.
    PubMed     Abstract available
    
    
    
43. JEENA L, Ferrand RA, Simms V, Kahari C, et al
    Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe: Erratum.
    AIDS. 2025;39:1674-1675.
    PubMed    
    
    
    
44. ANTWI S, Yang H, Enimil A, Martyn-Dickens C, et al
    Tenofovir diphosphate concentrations in dried blood spots predict future HIV suppression but not virologic failure in adolescents with HIV.
    AIDS. 2025;39:1668-1671.
    PubMed     Abstract available
    
    
    
45. ERLY S, Troupe D, Capizzi J, Amiya R, et al
    Increase in heterosexual transmission of HIV in international Pacific Northwest region (United States and Canada).
    AIDS. 2025;39:1666-1668.
    PubMed     Abstract available
    
    
    
46. RAHIM FO, Nguyen NT, Chen JK, Mahatara EV, et al
    A rollback on PEPFAR will have far-reaching consequences in global health.
    AIDS. 2025;39:1663-1665.
    PubMed    
    
    
    
47. EGAN JE, Hillier SL, Avery AK, Friedman MR, et al
    The great mismatch: unfulfilled promise of biomedical HIV prevention.
    AIDS. 2025;39:1658-1660.
    PubMed    
    
    
    
48. BEYRER C, Ratevosian J, Gelderblom H, Rosenberg NE, et al
    The HIV/AIDS pandemic: where are we now?
    AIDS. 2025;39:1497-1504.
    PubMed     Abstract available
    
    
    August 2025
49. KAMPHUIS AEM, Kiezebrink T, Waalewijn H, Bamford A, et al
    Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children living with HIV in the CHAPAS-4 trial.
    AIDS. 2025 Aug 26. doi: 10.1097/QAD.0000000000004328.
    PubMed     Abstract available
    
    
    
50. ZHAO H, Ye S, Lang G, Tang D, et al
    Serum triglyceride and high-density lipoprotein at admission are associated with 30-day overall mortality of patients with HIV and Talaromycosis.
    AIDS. 2025 Aug 26. doi: 10.1097/QAD.0000000000004327.
    PubMed     Abstract available
    
    
    
51. YU X, Carter M, Gao D, Nguyen N, et al
    Screening benefits for breast and colorectal cancer-specific survival among medicare enrollees with HIV.
    AIDS. 2025 Aug 19. doi: 10.1097/QAD.0000000000004325.
    PubMed     Abstract available
    
    
    
52. HAN WM, Wu K, Tassiopoulos K, Knowles K, et al
    Inflammation in frailty, cognitive impairment, clinical events and mortality among older adults with HIV in the ACTG HAILO cohort.
    AIDS. 2025 Aug 14. doi: 10.1097/QAD.0000000000004324.
    PubMed     Abstract available
    
    
    
53. INZAULE S, Silva R, Ford N, Thwin SS, et al
    Comparative analyses of COVID-19 in-hospital mortality in people living with HIV during SARS-CoV-2 pre-delta, delta, and omicron waves: data from the who global clinical platform.
    AIDS. 2025 Aug 14. doi: 10.1097/QAD.0000000000004323.
    PubMed     Abstract available
    
    
    
54. MENDES DE LEON KF, Nieuwkerk PT, Lemkes BA, Geerlings SE, et al
    Preferences for long-acting treatment among people with HIV: a discrete choice experiment.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004314.
    PubMed     Abstract available
    
    
    
55. IRIARTE E, Jones R, Wang CX, Hall CDX, et al
    Gait speed and neurocognition among older people with and without HIV.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004312.
    PubMed     Abstract available
    
    
    
56. THOME B, Pacola DP, Negra MD, Durigon GS, et al
    Persistent immunological repercussions of late antiretroviral initiation in children living with HIV.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004311.
    PubMed     Abstract available
    
    
    
57. MASCARELL P, Gutierrez-Ortiz de la Tabla A, Ledesma C, Fernandez-Gonzalez M, et al
    A decade of anal cancer screening in the context of HIV care: feasibility, acceptability, and long-term retention.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004313.
    PubMed     Abstract available
    
    
    
58. D'AMICO R, Han K, Min S, Demoor R, et al
    Subcutaneous injections of cabotegravir + rilpivirine long-acting in virally suppressed adults with HIV-1.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004310.
    PubMed     Abstract available
    
    
    
59. CALCAGNO A, Carola L, Barbara R, Marco M, et al
    Full reservoirs and poor adherence: two cases of symptomatic HIV cerebrospinal fluid escape with tenofovir alafenamide/emtricitabine/bictegravir.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004320.
    PubMed     Abstract available
    
    
    
60. DAI M, Chander G, Webel AR, Delaney JA, et al
    Alcohol use disorder, but not current alcohol use is associated with falls among people with HIV in care.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004317.
    PubMed     Abstract available
    
    
    
61. KARDASHIAN A, Golovaty I, Xia F, Ma Y, et al
    The association of food insecurity with hepatic steatosis in women with and without HIV.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004319.
    PubMed     Abstract available
    
    
    
62. NIYONGABO B, Tuyishime S, Nkurikiyintwali JMV, Mfuranziza C, et al
    Effects of test-and-treat versus preexposure prophylaxis on elimination of HIV transmission: analysis of 24 HIV prevention trials.
    AIDS. 2025;39:1484-1485.
    PubMed    
    
    
    
63. KAMITANI E, Koenig LJ, Sullivan P
    Transformative potential of artificial intelligence in US CDC HIV interventions: balancing innovation with health privacy.
    AIDS. 2025;39:1311-1321.
    PubMed     Abstract available
    
    
    July 2025
64. FILIP I
    As long-acting HIV prevention options gain momentum, the spotlight shifts to equitable access.
    AIDS. 2025 Jul 30. doi: 10.1097/QAD.0000000000004316.
    PubMed    
    
    
    
65. STEFFEN HM, Viola E, Thawani A, Kachere LG, et al
    Blood pressure, weight change and incident hypertension after switching to dolutegravir in treatment-experienced people living with HIV.
    AIDS. 2025 Jul 24. doi: 10.1097/QAD.0000000000004309.
    PubMed     Abstract available
    
    
    
66. ERLANDSON KM, Umbleja T, Ribaudo HJ, Lu MT, et al
    No evidence of pitavastatin effect on muscle area or density among people with HIV.
    AIDS. 2025 Jul 22. doi: 10.1097/QAD.0000000000004306.
    PubMed     Abstract available
    
    
    
67. MARCEAU T, Migraine J, Moreau A, Arrouche Y, et al
    Neutralizing antibodies and restriction factors cooperatively exert selective pressure on the HIV-1 envelope glycoprotein.
    AIDS. 2025 Jul 18. doi: 10.1097/QAD.0000000000004304.
    PubMed     Abstract available
    
    
    
68. ROED AKH, Reimer Jensen AM, Knudsen AD, Gelpi M, et al
    Elevated high-sensitivity C-reactive protein and triglycerides in people with HIV treated with lipid-lowering therapy.
    AIDS. 2025 Jul 18. doi: 10.1097/QAD.0000000000004305.
    PubMed     Abstract available
    
    
    
69. XUE K, Shi Y, Song F, Cai D, et al
    Glymphatic dysfunction in HIV: a resting-state fMRI biomarker linking cognitive impairment and immune suppression.
    AIDS. 2025 Jul 18. doi: 10.1097/QAD.0000000000004300.
    PubMed     Abstract available
    
    
    
70. COGHILL AE, Thompson Z, Bamford L, Burkholder G, et al
    The association of immunosuppression and HIV control with Kaposi sarcoma among patients on antiretroviral therapy.
    AIDS. 2025 Jul 18. doi: 10.1097/QAD.0000000000004303.
    PubMed     Abstract available
    
    
    
71. PINDER LF, Bertrand P, Fertitta V, Cahais V, et al
    Vaginal microbiome composition in women with HIV undergoing treatment of cervical transformation zone in a screen and treat program in Zambia.
    AIDS. 2025;39:1303-1306.
    PubMed     Abstract available
    
    
    
72. SUZUKI K, Levert A, Yoo E, Cysique LA, et al
    Higher levels of cell-associated HIV-1 RNA transcripts predict risk of viral blips: implications for clinical management and cure research.
    AIDS. 2025;39:1300-1302.
    PubMed     Abstract available
    
    
    
73. MASENGA SK, Anthony DD, Abdel-Hameed EA
    Microbial translocation and liver fibrosis in women with HIV - unraveling the gut-liver axis.
    AIDS. 2025;39:1297-1299.
    PubMed    
    
    
    
74. LUO G, Yan B, Shen Y
    The impact and mechanism of HIV infection on tuberculous granuloma formation.
    AIDS. 2025;39:1095-1105.
    PubMed     Abstract available
    
    
    
75. FILIP I
    Evolving data on heart failure reshape prevention and treatment strategies for people with HIV.
    AIDS. 2025 Jul 15. doi: 10.1097/QAD.0000000000004299.
    PubMed    
    
    
    
76. ZHOU Q, Chen X, Shen W, Wang S, et al
    Risk factors of incident physical frailty in middle-aged and older people with and without HIV: evidence from the CHART cohort.
    AIDS. 2025 Jul 15. doi: 10.1097/QAD.0000000000004298.
    PubMed     Abstract available
    
    
    
77. DARJI D, Norris S, Ohuma EO, Hemelaar J, et al
    Foetal growth in pregnant women with HIV: longitudinal analysis of serial ultrasound measurements in South Africa.
    AIDS. 2025 Jul 8. doi: 10.1097/QAD.0000000000004294.
    PubMed     Abstract available
    
    
    
78. ZANG X, Sui Y, Bessey S, Van TM, et al
    On the compounding manifestations of racism shaping the US HIV/AIDS epidemic: Why Ending the HIV Epidemic must address these factors for success.
    AIDS. 2025 Jul 7. doi: 10.1097/QAD.0000000000004289.
    PubMed     Abstract available
    
    
    
79. WIJSTMA ES, Jongen VW, Boyd A, De Vries HJC, et al
    Subpopulations with frequent healthcare barriers have increased risk of sexually transmitted infections and dropping out from HIV pre-exposure prophylaxis care.
    AIDS. 2025 Jul 2. doi: 10.1097/QAD.0000000000004224.
    PubMed     Abstract available
    
    
    
80. HWANG YJ, Lesko CR, Brown TT, Alexander GC, et al
    Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV: Erratum.
    AIDS. 2025;39:1094.
    PubMed    
    
    
    
81. YADAV A, Gionet G, Karaj A, Kossenkov AV, et al
    Association of smoking with neurocognition, inflammatory and myeloid cell activation profiles in people with HIV on antiretroviral therapy: Erratum.
    AIDS. 2025;39:1093.
    PubMed    
    
    
    
82. OTTO M, Okango E, Mee P, Dobra A, et al
    Trends in population HIV viral suppression: a longitudinal analysis.
    AIDS. 2025;39:1088-1092.
    PubMed     Abstract available
    
    
    
83. PREVEDEN A, Garipi E, Bogdan M, Preveden M, et al
    Influence of disturbed blood flow on endothelial function in people with HIV.
    AIDS. 2025;39:1086-1088.
    PubMed     Abstract available
    
    
    
84. TINCATI C, Fusco FM, Santoro A, de Iaco F, et al
    HIV screening in the emergency department: an opinion piece by the Italian Societies of Infectious Diseases and Emergency Medicine.
    AIDS. 2025;39:927-934.
    PubMed    
    
    
    June 2025
85. MARCUS ME, Zang E, Hove J, Jordan H, et al
    Left behind? A longitudinal analysis of need for PrEP services among middle-aged and older adults in South Africa.
    AIDS. 2025 Jun 27. doi: 10.1097/QAD.0000000000004283.
    PubMed     Abstract available
    
    
    
86. HOPWOOD-RAJA JJ, Tseng AL, Sheehan NL, Walmsley SL, et al
    CHANGE-Rx: frailty, falls, polypharmacy, and inappropriate medication use in a canadian cohort of people aged 65 and older living with HIV.
    AIDS. 2025 Jun 27. doi: 10.1097/QAD.0000000000004284.
    PubMed     Abstract available
    
    
    
87. MEYER-RATH G, Jamieson L, Mudimu E, Imai-Eaton JW, et al
    The cost of the plunge: The impact and cost of a cessation of PEPFAR-supported services in South Africa.
    AIDS. 2025 Jun 23. doi: 10.1097/QAD.0000000000004272.
    PubMed     Abstract available
    
    
    
88. BUCKLEY J, Cassim H, Otwombe K, Hlongwane K, et al
    Neurocognitive functioning in women living with HIV: A comparative study in a Low/Middle-income Country.
    AIDS. 2025 Jun 23. doi: 10.1097/QAD.0000000000004277.
    PubMed     Abstract available
    
    
    
89. CHOW D, Pronyk P, Mgimba R, Elimwaria W, et al
    Integrating a mental health referral system within adolescent HIV clinics in Tanzania.
    AIDS. 2025 Jun 19. doi: 10.1097/QAD.0000000000004279.
    PubMed     Abstract available
    
    
    
90. VO AT, Wynn A, Hernandez M, Terris-Prestholt F, et al
    Unit Costs of Opioid Agonist Therapy (OAT): A Global Systematic review and cost Extrapolation.
    AIDS. 2025 Jun 13. doi: 10.1097/QAD.0000000000004263.
    PubMed     Abstract available
    
    
    
91. AYER A, Mukondwa RW, Aviles Guaman C, Takarinda K, et al
    Poverty and protection: the relationship between multidimensional poverty, social protections interventions, and HIV viral load.
    AIDS. 2025 Jun 13. doi: 10.1097/QAD.0000000000004276.
    PubMed     Abstract available
    
    
    
92. ERLANDSON KM, McKhann A, Kitch DW, Palella FJ, et al
    No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV.
    AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004267.
    PubMed     Abstract available
    
    
    
93. GRIFFITHS PM, Samra R, Lester G, Rawson-Harris P, et al
    Cervical cancer screening in women living with HIV: an audit of clinical care.
    AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004266.
    PubMed     Abstract available
    
    
    
94. ZHAO OS, Silver HJ, Fan R, Ye F, et al
    Subcutaneous adipose tissue gene transcripts associated with progressive myosteatosis in persons with HIV.
    AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004264.
    PubMed     Abstract available
    
    
    
95. HAGE K, Boyd A, Davidovich U, Generaal E, et al
    The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the pre-randomization phase of a clinical trial.
    AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004265.
    PubMed     Abstract available
    
    
    
96. BEDDEK K, Boufassa F, Mouanga C, Bitu M, et al
    Higher plasma concentrations of von Willebrand factor in women than in men during both the acute and chronic phases of HIV infection.
    AIDS. 2025 Jun 10. doi: 10.1097/QAD.0000000000004253.
    PubMed     Abstract available
    
    
    
97. SUKUMARAN L, Winston A, Post FA, Anderson J, et al
    Changes in multimorbidity burden and their impact on patient and healthcare outcomes in people with HIV over a 3-5-year period.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004260.
    PubMed     Abstract available
    
    
    
98. BAUGHER AR, Wejnert C, Kanny D, Broz D, et al
    Are we ending the HIV epidemic among persons who inject drugs?: Key findings from 19 U.S. cities, 2022.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004249.
    PubMed     Abstract available
    
    
    
99. MAGUT F, Mazibuko L, Mthiyane N, Harling G, et al
    Hiv and herpes simplex virus 2 incidence among adolescent girls and young women who sell sex (YWSS) in rural south africa: a population-based cohort study.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004255.
    PubMed     Abstract available
    
    
    
100. FITTIPALDI J, Cardoso SW, Nunes EP, De Almeida CF, et al
     Metabolic dysfunction-associated steatotic liver disease (MASLD) was associated with liver fibrosis in people living with HIV from Brazil.
     AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004250.
     PubMed     Abstract available
     
     
     
101. KOETHE JR, Robles ME, Widmer A, Lillegard K, et al
     Lower skeletal muscle density on CT imaging is associated with incomplete fatty acid oxidation, as measured by plasma acylcarnitines, in men with HIV.
     AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004258.
     PubMed     Abstract available
     
     
     
102. MATA MARIN JA, Rodriguez Evaristo MS, Cano Diaz AL, Salinas Velazquez GE, et al
     Incidence of Metabolic syndrome in people with HIV without experienCe to antiretroviral Therapy who start doLutegravir based-regimen compared with bictegrAvir based-regimeN after 48 weeks (MICTLAN trial).
     AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004259.
     PubMed     Abstract available
     
     
     
103. MERAD Y, Mariaggi AA, Karmochkine M, Slama L, et al
     Virological success despite archived INSTI drug resistance mutations on INSTI-based antiretroviral regimens.
     AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004251.
     PubMed     Abstract available
     
     
     
104. WALPERT AR, Gupta M, Dunderdale CN, Haptu HH, et al
     Exploring the PREVENT HF score and myocardial function among persons with HIV.
     AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004252.
     PubMed     Abstract available
     
     
     
105. BERNAL E, Martinez-Rodriguez R, Gomez JM, Tomas C, et al
     Low-level viremia linked to virological failure but not clinical events: a competing risks study.
     AIDS. 2025 Jun 3. doi: 10.1097/QAD.0000000000004248.
     PubMed     Abstract available
     
     
     
106. LOABILE B, Bilker WB, Khunou K, Ngwako N, et al
     Association of HIV status with infections complicating abortion in Botswana.
     AIDS. 2025;39:923-926.
     PubMed     Abstract available
     
     
     
107. MAROZIN S, Bono V, Mazzoccoli M, Augello M, et al
     Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection.
     AIDS. 2025;39:921-923.
     PubMed     Abstract available
     
     
     
108. VAN DE PERRE P, Moore PL, Nagot N, Gama L, et al
     Broadly neutralizing antibodies, nonneutralizing antibodies and broadly effector antibodies to prevent HIV transmission?
     AIDS. 2025;39:918-920.
     PubMed    
     
     
     
109. FILIP I
     Will long-acting HIV preexposure prophylaxis live up to its promise?
     AIDS. 2025;39:N11-N12.
     PubMed    
     
     
     May 2025
110. YAP SH, Hisham S, Ho WY, Hor WBW, et al
     Cross sectional analysis of factors associated with low intrinsic capacity among Malaysians ageing with HIV in ambulatory care.
     AIDS. 2025 May 23. doi: 10.1097/QAD.0000000000004246.
     PubMed     Abstract available
     
     
     
111. DEFILIPPI C, Awwad A, Bloomfield GS, Weir IR, et al
     Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial.
     AIDS. 2025 May 23. doi: 10.1097/QAD.0000000000004243.
     PubMed     Abstract available
     
     
     
112. ROBERTS ST, Browne EN, Denson D, Moore E, et al
     Longer-acting pre-exposure prophylaxis product and delivery preferences among U.S. populations disproportionately affected by HIV: a discrete choice experiment.
     AIDS. 2025 May 23. doi: 10.1097/QAD.0000000000004247.
     PubMed     Abstract available
     
     
     
113. VYAS KJ, Marconi VC, Agan BK, Sullivan PS, et al
     Posttraumatic stress disorder and its associations with morbidity and mortality among veterans with HIV.
     AIDS. 2025 May 22. doi: 10.1097/QAD.0000000000004241.
     PubMed     Abstract available
     
     
     
114. WANG D, Michel KG, Umans JG, Dalby S, et al
     Fetoplacental arteriolar dysfunction in placentas of HIV-exposed, small for gestational age birthweight neonates.
     AIDS. 2025 May 22. doi: 10.1097/QAD.0000000000004242.
     PubMed     Abstract available
     
     
     
115. DING Y, Li J, Gao C, Xing L, et al
     Machine learning algorithms to predict the risk of hyperlipidemia in people living with HIV after starting HAART for 6 months.
     AIDS. 2025 May 21. doi: 10.1097/QAD.0000000000004244.
     PubMed     Abstract available
     
     
     
116. THITIPATARAKORN S, Teeratakulpisarn N, Nonenoy S, Klinsukontakul A, et al
     The natural history of anal high-grade squamous intraepithelial lesions among men who have sex with men and transgender women in an acute HIV cohort in Thailand.
     AIDS. 2025 May 19. doi: 10.1097/QAD.0000000000004238.
     PubMed     Abstract available
     
     
     
117. MORAKA NO, Ralegoreng C, Lemogang GM, Makwakwa R, et al
     HIV-1 infection recency among individuals newly diagnosed with HIV in Greater Gaborone, Botswana.
     AIDS. 2025 May 19. doi: 10.1097/QAD.0000000000004239.
     PubMed     Abstract available
     
     
     
118. NICASTRO TM, Mocello AR, Weke E, Bukusi EA, et al
     Effect of a climate-smart intervention on agriculture and nutrition of people with HIV: a cluster-randomized trial.
     AIDS. 2025 May 15. doi: 10.1097/QAD.0000000000004234.
     PubMed     Abstract available
     
     
     
119. HAMILTON DT, Hoover KW, Delaney KP
     Reducing HIV incidence in the southern US through routine opt-out HIV screening.
     AIDS. 2025 May 15. doi: 10.1097/QAD.0000000000004237.
     PubMed     Abstract available
     
     
     
120. APPLETON AA, Lee S, Kuniholm MH, Vasquez E, et al
     Adverse childhood experiences, sexual orientation-related victimization, and cardiovascular disease risk among men living with and without HIV.
     AIDS. 2025 May 15. doi: 10.1097/QAD.0000000000004235.
     PubMed     Abstract available
     
     
     
121. JIA C, Peters BA, Usyk M, Wang Z, et al
     Associations of fecal and blood microbiota-related metabolites with gut microbiota and type 2 diabetes in HIV infection.
     AIDS. 2025 May 6. doi: 10.1097/QAD.0000000000004231.
     PubMed     Abstract available
     
     
     
122. GARRATT A, Muraleetharan A, Fairhead C, Hill A, et al
     Effects of Test-and-Treat versus PrEP on elimination of HIV transmission: analysis of 24 HIV prevention trials.
     AIDS. 2025 May 5. doi: 10.1097/QAD.0000000000004232.
     PubMed     Abstract available
     
     
     
123. MEZZADRI L, Soria AG, Ranzani A, Malandrin S, et al
     Hepatitis B core antibody positivity is not associated with risk of transaminase elevation following switch to dual antiretroviral therapy.
     AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004227.
     PubMed     Abstract available
     
     
     
124. DOS SANTOS AP, Willig AL, Ruderman SA, Oliveira VHF, et al
     The lipid research clinics physical activity questionnaire does not accurately measure physical activity in people with HIV.
     AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004226.
     PubMed     Abstract available
     
     
     
125. CLEMENTE T, Bellomo M, Raccagni AR, Lolatto R, et al
     Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIV.
     AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004225.
     PubMed     Abstract available
     
     
     
126. MATARAMVURA H, Jordan-Paiz A, Naidoo K, Jaeger J, et al
     Altered mitochondrial mass and fatty acid uptake by NK cells in HIV-exposed uninfected children at 6 years of age.
     AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004228.
     PubMed     Abstract available
     
     
     
127. ABDALLA S, Compagnucci A, Bamford A, Chan MK, et al
     Assessment of the steady-state drug-drug interactions between dolutegravir and ritonavir-boosted darunavir in adolescents.
     AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004223.
     PubMed     Abstract available
     
     
     
128. BUSZA J, Machingura F, Kujeke T, Makamba M, et al
     What happened with preexposure prophylaxis uptake among female sex workers in Zimbabwe? Implications for future prevention programmes.
     AIDS. 2025;39:771-773.
     PubMed    
     
     
     
129. HATCHER AM, Metheny N, Dunkle KL, Fielding-Miller R, et al
     A refusal to abandon HIV science.
     AIDS. 2025;39:768-770.
     PubMed    
     
     
     
130. MELDRUM BG, McGee-Avila JK, Luo Q, Milan J Jr, et al
     Racial disparities in cancer risk among MSM with HIV in the United States.
     AIDS. 2025;39:728-736.
     PubMed     Abstract available
     
     
     
131. PARCZEWSKI M, Boesecke C, Khaykin P, Jilich D, et al
     Provision of care for people with HIV migrating from Ukraine: preparing for a long-term response.
     AIDS. 2025;39:629-638.
     PubMed     Abstract available
     
     
     April 2025
132. WATI DK, Nguyen LV, Quy DT, Nguyen DQ, et al
     Outcomes of children living with HIV during the COVID-19 pandemic in Vietnam.
     AIDS. 2025 Apr 24. doi: 10.1097/QAD.0000000000004222.
     PubMed     Abstract available
     
     
     
133. FILIP I
     Inflammation and silent myocardial damage may play a key role in predicting cardiovascular risk for people with HIV.
     AIDS. 2025 Apr 24. doi: 10.1097/QAD.0000000000004211.
     PubMed    
     
     
     
134. ZHANG R, Chung SL, Lee SS, Wong NS, et al
     Prevalence and resistance patterns of Mycoplasma genitalium infection in people living with HIV: a systematic review and meta-analysis.
     AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004219.
     PubMed     Abstract available
     
     
     
135. TENKORANG EY
     The health impact of spiritual intimate partner abuse among women living with HIV in Ghana.
     AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004221.
     PubMed     Abstract available
     
     
     
136. HILL A, Fairhead C, Manalu S, Venter F, et al
     Could reduced dosing maintain more people on antiretrovirals after the sudden cuts in USAID funding? A crisis response.
     AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004212.
     PubMed     Abstract available
     
     
     
137. HEJBLUM G, Daher S, Moulaire P, Amat K, et al
     Cost-effectiveness of a 4 days-a-week triple therapy in persons living with HIV: an ancillary study of the QUATUOR trial.
     AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004215.
     PubMed     Abstract available
     
     
     
138. BUCHWALD AG, Crespo-Llado MM, Maliwichi L, Mdhluli C, et al
     The effect of environment and in utero HIV exposure on neurodevelopment in infants.
     AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004217.
     PubMed     Abstract available
     
     
     
139. ELLIS J, Dai B, Kabahubya M, Hale G, et al
     Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease: a prospective cohort study.
     AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004213.
     PubMed     Abstract available
     
     
     
140. YANG X, Chen X, Shen W, Wang S, et al
     Post antiretroviral treatment dynamics of blood EBV DNA among people with HIV: A prospective cohort study.
     AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004214.
     PubMed     Abstract available
     
     
     
141. OH TK, Song KH, Heo E, Song IA, et al
     Association between HIV and cancer risk: a nationwide, population-based cohort study.
     AIDS. 2025 Apr 15. doi: 10.1097/QAD.0000000000004210.
     PubMed     Abstract available
     
     
     
142. NAMPOTA-NKOMBA N, Mohanty K, Adebiyi R, Ekeh C, et al
     Penile human papillomavirus prevalence in circumcised sexual minority men living with and without HIV.
     AIDS. 2025 Apr 15. doi: 10.1097/QAD.0000000000004209.
     PubMed     Abstract available
     
     
     
143. BOUWMEESTER TA, van der Wulp IAJ, Kusi Mensah YA, Wit FWNM, et al
     Impaired autonomic cardiovascular control in people with HIV on long-term successful treatment.
     AIDS. 2025 Apr 10. doi: 10.1097/QAD.0000000000004208.
     PubMed     Abstract available
     
     
     
144. DUARTE HA, Birnbaum JK, Carlucci JG, Ghazal Y, et al
     Modeling the potential impact of viral load monitoring on vertical transmission of HIV in Kenya.
     AIDS. 2025 Apr 10. doi: 10.1097/QAD.0000000000004207.
     PubMed     Abstract available
     
     
     
145. LI Y, Soto-Ramirez ZN, Roscher J, Medvec T, et al
     Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence.
     AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004204.
     PubMed     Abstract available
     
     
     
146. VAN DER MANNEN JS, Furamera S, Pienaar J, Komane P, et al
     Predictors of unsuppressed viral load among men who have sex with men living with HIV in South Africa.
     AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004205.
     PubMed     Abstract available
     
     
     
147. WANG L, Li SM, Li X, Wu HS, et al
     The transmembrane nucleoporin Nup210 weakens HIV-1 infection via modulating late events of viral nuclear import.
     AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004206.
     PubMed     Abstract available
     
     
     
148. GLENN JS, Bennett A, Mackie N, Lyall H, et al
     The cumulative prevalence of HIV-1 drug resistance in perinatal HIV.
     AIDS. 2025 Apr 4. doi: 10.1097/QAD.0000000000004202.
     PubMed     Abstract available
     
     
     
149. ADAMSON PC, Bui HTM, Pham LQ, Truong PT, et al
     Routine testing for chlamydia and gonorrhea in an HIV Pre-Exposure prophylaxis program in hanoi, vietnam: implications for low- and middle-income countries.
     AIDS. 2025 Apr 4. doi: 10.1097/QAD.0000000000004203.
     PubMed     Abstract available
     
     
     
150. BENZEKRI NA, Plaisy MK, Koffi JJ, Mensah E, et al
     Food insecurity and mental health outcomes among people living with HIV in West Africa.
     AIDS. 2025 Apr 3. doi: 10.1097/QAD.0000000000004200.
     PubMed     Abstract available
     
     
     
151. MOLLAN KR, Pence BW, Westreich D, Bula A, et al
     Effectiveness of levonorgestrel implant and depot medroxyprogesterone acetate injectable for women living with HIV on efavirenz: a prospective cohort study.
     AIDS. 2025 Apr 3. doi: 10.1097/QAD.0000000000004201.
     PubMed     Abstract available
     
     
     
152. SHAH S, Short CE, Taylor G, Lyall H, et al
     Comparison of pregnancy outcomes between people with perinatally acquired HIV, horizontally acquired HIV and those without HIV.
     AIDS. 2025;39:621-624.
     PubMed     Abstract available
     
     
     
153. RAMASWAMI R, Kelesidis T, Goedert JJ
     When cytokine storms collide: understanding hemophagocytic lymphohistiocytosis in human herpesvirus 8/Kaposi sarcoma herpesvirus-associated multicentric Castleman disease among people with HIV.
     AIDS. 2025;39:618-620.
     PubMed    
     
     
     
154. SAMAHA J, Madhu S, Shehadeh LA, Martinez CA, et al
     Osteopontin as a potential mediator of inflammation in HIV and comorbid conditions.
     AIDS. 2025;39:483-495.
     PubMed     Abstract available
     
     
     
155. RIOS-VAZQUEZ V, Vos WAJW, Blaauw MJT, Van Eekeren LE, et al
     Dolutegravir plus lamivudine downregulates cellular stress responses versus three-drug HIV Regimens.
     AIDS. 2025 Apr 1. doi: 10.1097/QAD.0000000000004198.
     PubMed     Abstract available
     
     
     
156. YANG GW, Zhou QW, Zhen X, Yang Y, et al
     A promising prognostic model for patients with AIDS-related lymphoma in the cART era.
     AIDS. 2025 Apr 1. doi: 10.1097/QAD.0000000000004197.
     PubMed     Abstract available
     
     
     March 2025
157. LIN LY, Ferte T, Chachage M, Casteano C, et al
     Deciphering HIV vaccine-induced Antibody response according to ethnicity.
     AIDS. 2025 Mar 31. doi: 10.1097/QAD.0000000000004196.
     PubMed     Abstract available
     
     
     
158. KAMITANI E, DeLuca JB, Mizuno Y
     Systematic review of infodemiology studies using artificial intelligence: social media posts on HIV pre-exposure prophylaxis.
     AIDS. 2025 Mar 27. doi: 10.1097/QAD.0000000000004193.
     PubMed     Abstract available
     
     
     
159. MARTINSON T, Heise MJ, Sassaman K, Schmidt HR, et al
     Interest and disparities in awareness and uptake of doxyPEP among U.S. MSM living with HIV.
     AIDS. 2025 Mar 27. doi: 10.1097/QAD.0000000000004192.
     PubMed     Abstract available
     
     
     
160. DUARTE MJ, Tien PC, Kardashian A, Ma Y, et al
     Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV.
     AIDS. 2025 Mar 25. doi: 10.1097/QAD.0000000000004189.
     PubMed     Abstract available
     
     
     
161. ZHANG L, Chen N, Wang X, Du J, et al
     Increased frequency of Foxp3+CD8+ T cells are associated with disease progression during HIV infection.
     AIDS. 2025 Mar 20. doi: 10.1097/QAD.0000000000004185.
     PubMed     Abstract available
     
     
     
162. REIS K, Stephano PF, Fadhil S, Willkens M, et al
     Arterial stiffness in people with HIV: a cross-sectional, comparative study with echocardiographic outcomes in Tanzania.
     AIDS. 2025 Mar 20. doi: 10.1097/QAD.0000000000004184.
     PubMed     Abstract available
     
     
     
163. ANDERSON K, Eley BS, Rabie H, Muloiwa R, et al
     Hospitalisation incidence among young children living with HIV in the Western Cape, South Africa.
     AIDS. 2025 Mar 18. doi: 10.1097/QAD.0000000000004156.
     PubMed     Abstract available
     
     
     
164. BEYDOUN N, Nance RM, Durstenfeld MS, Hoffmann AP, et al
     Multicenter study of heart failure phenotypes and physician-adjudicated etiologies in people with HIV.
     AIDS. 2025 Mar 18. doi: 10.1097/QAD.0000000000004182.
     PubMed     Abstract available
     
     
     
165. SORENSEN EF, Hybel TE, Ludvigsen M
     Response to correspondence piece on 'Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes'.
     AIDS. 2025;39:481.
     PubMed    
     
     
     
166. DAUNGSUPAWONG H, Wiwanitkit V
     Characterization of the genomic landscape of HIV-associated lymphoma.
     AIDS. 2025;39:480.
     PubMed    
     
     
     
167. BELLOMO M, Gianotti N, Hasson H, Canetti D, et al
     Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimens.
     AIDS. 2025;39:477-479.
     PubMed     Abstract available
     
     
     
168. MUCCINI C, Spagnuolo V, Zazzi M, Castagna A, et al
     People with four-class drug-resistant HIV-1 may have low levels of intact DNA.
     AIDS. 2025;39:475-476.
     PubMed     Abstract available
     
     
     
169. BABALOLA CM, Peters RPH, Muzny CA, Davey DJ, et al
     From pregnancy to beyond: renewed emphasis on comprehensive HIV prevention in South Africa.
     AIDS. 2025;39:470-474.
     PubMed     Abstract available
     
     
     
170. GOODKIN K
     Sleep in the context of neuropsychiatric and primary medical comorbidity patterns among people with HIV.
     AIDS. 2025;39:467-469.
     PubMed    
     
     
     
171. COHN SE
     Women with HIV: increased need for reproductive health services to improve health outcomes.
     AIDS. 2025;39:464-466.
     PubMed    
     
     
     
172. BARBER TJ, Gonzalez-Scarano F, Vance DE
     Cognitive dysfunction in people with HIV: the potential effect of personal and environmental circumstances.
     AIDS. 2025;39:462-463.
     PubMed    
     
     
     
173. SHORT WR, Rakhmanina N
     Expanding choices of antiretroviral treatment regimens for pregnant and breastfeeding persons with HIV.
     AIDS. 2025;39:459-461.
     PubMed    
     
     
     
174. KUHN L, Thomas P
     Studies of young adults with perinatal HIV infection provide new clues for HIV cure.
     AIDS. 2025;39:457-458.
     PubMed    
     
     
     
175. LUCEY M, Burns F, Bhagani S, Lipman M, et al
     SARS-CoV-2 antibody prevalence in adults living with HIV.
     AIDS. 2025 Mar 13. doi: 10.1097/QAD.0000000000004180.
     PubMed     Abstract available
     
     
     
176. KONSTANTINIDIS I, Papageorgiou SN, Zou RH, Ronit A, et al
     Effect of HIV on respiratory symptoms, health status, and exertional capacity: a systematic review and meta-analysis.
     AIDS. 2025 Mar 13. doi: 10.1097/QAD.0000000000004179.
     PubMed     Abstract available
     
     
     
177. DAO TTD, Filipowicz TR, Edmonds A, Ramirez C, et al
     Depressive symptoms among women of reproductive age with and without HIV in the Southern United States: baseline description from the STAR cohort.
     AIDS. 2025 Mar 13. doi: 10.1097/QAD.0000000000004181.
     PubMed     Abstract available
     
     
     
178. IZQUIERDO R, Rava M, Gutierrez F, Garcia-Fraile LJ, et al
     Increased mortality and morbidity risk in people with early HIV care interruption in Spain, 2004-2023.
     AIDS. 2025 Mar 10. doi: 10.1097/QAD.0000000000004175.
     PubMed     Abstract available
     
     
     
179. MAZZITELLI M, Krankowska D, Cozzolino C, Scaglione V, et al
     Sexual health knowledge, interest and acceptability of PrEP in migrant women: the MIMOSA study.
     AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004174.
     PubMed     Abstract available
     
     
     
180. LIEBZEIT CJ, Deng HY, Liang B, Li L, et al
     Unique expression of genes influencing transendothelial leukocyte migration in HIV-1 resistant women in the pumwani sex worker cohort.
     AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004177.
     PubMed     Abstract available
     
     
     
181. SCHMIDT HR, Heise MJ, Sassaman K, D'Angelo A, et al
     High viral suppression amid demographic disparities: a U.S. national cohort of people with HIV on a popular dating app.
     AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004173.
     PubMed     Abstract available
     
     
     
182. INZAULE S, Jordan MR, Fokam J, Hamers RL, et al
     Non-canonical HIV drug resistance mutations: need to close existing gaps.
     AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004170.
     PubMed     Abstract available
     
     
     
183. MUNK K, Suarez-Zdunek MA, Krabek R, Hamm SR, et al
     Association between low skeletal muscle mass and lung function decline in people with HIV: a prospective cohort study.
     AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004172.
     PubMed     Abstract available
     
     
     
184. JORDANS CCE, Vliegenthart-Jongbloed K, Osbak KK, Hanssen JLJ, et al
     Implementing HIV teams sustainably improves HIV indicator condition testing rates in hospitals in the Netherlands: the #aware.hiv clinical trial.
     AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004167.
     PubMed     Abstract available
     
     
     
185. PIGGOTT DA, Mehta SH, Rubin LH, Sun J, et al
     Cognitive function and mortality among persons aging with HIV and injection drug use.
     AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004169.
     PubMed     Abstract available
     
     
     
186. OLIVEIRA VH, Willig AL, Davey CH, Buford TW, et al
     Abdominal adiposity is negatively associated with physical function among people with HIV.
     AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004168.
     PubMed     Abstract available
     
     
     
187. MOYLE G, Gruber J, Dunbar M, Radtchenko J, et al
     Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruption.
     AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004171.
     PubMed     Abstract available
     
     
     
188. CASPER SJ, Fix ML, Spivak AM
     A blind spot in HIV diagnosis guidelines?
     AIDS. 2025;39:334-335.
     PubMed    
     
     
     
189. ZHEN XM, Liu ZH, Zhang L, Xiao F, et al
     Epstein-Barr virus-associated smooth muscle tumor with multiple lesions in a patient with AIDS.
     AIDS. 2025;39:330-333.
     PubMed     Abstract available
     
     
     
190. MARZIALI ME, Kooij KW, Zhang W, Budu M, et al
     Fatal overdoses among people with HIV experiencing nonfatal overdoses in British Columbia, Canada.
     AIDS. 2025;39:328-330.
     PubMed     Abstract available
     
     
     
191. TAO J, Maguire-Wilkerson A, Rusley J, Wray T, et al
     Implementing conversational artificial intelligence technology for the prevention of HIV and other sexually transmitted infections in real-world settings.
     AIDS. 2025;39:324-327.
     PubMed    
     
     
     
192. GOODKIN K, Pollack HA
     Contextual factors related to the overlap of the overdose and HIV pandemics and their clinical implications.
     AIDS. 2025;39:321-323.
     PubMed    
     
     
     
193. NGENO GTK, Bloomfield GS
     Global health solidarity in the HIV and hypertension disease response.
     AIDS. 2025;39:319-320.
     PubMed    
     
     
     
194. BRENNER BG, Fairlie L
     The need to avert emergent resistance to dolutegravir in children and adolescents with HIV.
     AIDS. 2025;39:317-318.
     PubMed    
     
     
     
195. BENNETT T, Walmsley S, Bendayan R
     Aging with HIV and HIV-associated neurocognitive impairment.
     AIDS. 2025;39:215-228.
     PubMed     Abstract available
     
     
     February 2025
196. NAJJUUKO C, Brathwaite R, Xu Z, Kizito S, et al
     Using machine learning to predict poor adherence to antiretroviral therapy among adolescents living with HIV in low resource settings.
     AIDS. 2025 Feb 25. doi: 10.1097/QAD.0000000000004163.
     PubMed     Abstract available
     
     
     
197. WHELTON SP, Haberlen SA, Zhang L, Herrschaft R, et al
     Associations between HIV serostatus and coronary artery plaque volume progression.
     AIDS. 2025 Feb 25. doi: 10.1097/QAD.0000000000004165.
     PubMed     Abstract available
     
     
     
198. TAM C, Zhang W, Moore D, Salters K, et al
     Impacts of overdose and socio-structural factors on recent mortality among people living with HIV in British Columbia, Canada.
     AIDS. 2025 Feb 24. doi: 10.1097/QAD.0000000000004158.
     PubMed     Abstract available
     
     
     
199. CHALOUNI M, Van Santen DK, Berenguer J, Jarrin I, et al
     Time to direct-acting antivirals initiation and liver-related events in people with HIV and Hepatitis C virus.
     AIDS. 2025 Feb 19. doi: 10.1097/QAD.0000000000004161.
     PubMed     Abstract available
     
     
     
200. LI W, Egler A, Oyungu E, Yang Z, et al
     Pro- and anti-inflammatory immune biomarkers as predictors of neurodevelopment in young children exposed to HIV.
     AIDS. 2025 Feb 19. doi: 10.1097/QAD.0000000000004162.
     PubMed     Abstract available
     
     
     
201. NUHN MM, Bosman K, Huisman T, Staring WHA, et al
     Selective decline of intact HIV reservoirs during the first decade of ART followed by stabilization in memory T cell subsets.
     AIDS. 2025 Feb 17. doi: 10.1097/QAD.0000000000004160.
     PubMed     Abstract available
     
     
     
202. VAN PAASSEN PM, Boyd AC, Pasternak AO, Maurer I, et al
     Soluble CD14 and IL-12p70 on early ART predict HIV load setpoint after treatment interruption.
     AIDS. 2025 Feb 14. doi: 10.1097/QAD.0000000000004159.
     PubMed     Abstract available
     
     
     
203. FILIP I
     Transplantation of kidneys from donors with HIV: are we there yet?
     AIDS. 2025 Feb 13. doi: 10.1097/QAD.0000000000004155.
     PubMed    
     
     
     
204. SHEIRA LA, Kwena ZA, Ayieko B, Charlebois ED, et al
     The effect of a social network-based intervention on adherence to HIV pre-exposure prophylaxis and HIV viral suppression among Kenyan fishermen.
     AIDS. 2025 Feb 13. doi: 10.1097/QAD.0000000000004157.
     PubMed     Abstract available
     
     
     
205. RAMI A, Pozniak AL, Assoumou L, Movahedi R, et al
     Use of doravirine-based regimens in clinical practice in Europe: a real-life retrospective observational study.
     AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004151.
     PubMed     Abstract available
     
     
     
206. HERLIHY JM, Zulu E, Mwananyanda L, Forman L, et al
     Risk of hospitalization or death does not differ in children exposed to HIV, yet uninfected compared to non-exposed peers in the Zambia Infant Cohort Study (ZICS).
     AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004152.
     PubMed     Abstract available
     
     
     
207. BALDIN G, Salvo PF, Passerotto RA, Iannone V, et al
     'With age comes wisdom': effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV.
     AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004153.
     PubMed     Abstract available
     
     
     
208. VOLESKY-AVELLANEDA KD, Luo Q, Amaswami RR, Lurain K, et al
     Primary effusion lymphoma in people with and without HIV infection in the United States.
     AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004154.
     PubMed     Abstract available
     
     
     
209. AGBEY C, Walton S, Campbell LA, Nath A, et al
     Expression of human immunodeficiency virus envelope protein in the human central nervous system.
     AIDS. 2025 Feb 11. doi: 10.1097/QAD.0000000000004150.
     PubMed     Abstract available
     
     
     
210. MATOVU KIWEEWA F, Stranix-Chibanda L, Yende-Zuma N, Dadabhai S, et al
     Bone mineral density changes in breastfeeding women living with HIV on antiretroviral therapy in Eastern and Southern Africa.
     AIDS. 2025 Feb 7. doi: 10.1097/QAD.0000000000004148.
     PubMed     Abstract available
     
     
     
211. KNOX J, Magana C, Duncan DT, Shrader CH, et al
     Cannabis use and HIV among Black sexually minoritized men: a systematic review and narrative analysis.
     AIDS. 2025 Feb 7. doi: 10.1097/QAD.0000000000004149.
     PubMed     Abstract available
     
     
     
212. MARSEILLE E, Walker RS, Hickey MD, Grochowski J, et al
     Cost-effectiveness of long-acting injectable cabotegravir-rilpivirine as HIV treatment per virally-suppressed persons in a San Francisco clinic: an intermediary outcome analysis.
     AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004145.
     PubMed     Abstract available
     
     
     
213. OGBUAGU OE, Avihingsanon A, Segal-Maurer S, Wang H, et al
     Efficacy, safety, and pharmacokinetics of lenacapavir oral bridging when subcutaneous lenacapavir cannot be administered.
     AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004142.
     PubMed     Abstract available
     
     
     
214. HICKS S, Jiang W, Kibugi J, Badia J, et al
     Sociobehavioral determinants of non-retention among adolescents and young adults living with HIV.
     AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004141.
     PubMed     Abstract available
     
     
     
215. VIGUERIE A, O'Shea J, Johnston M, Schreiber D, et al
     Impact of increased uptake of long-acting injectable antiretroviral therapy on HIV incidence and viral suppression in the United States under 2021 FDA guidelines.
     AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004144.
     PubMed     Abstract available
     
     
     
216. JACKSON C, Crichton S, Judd A, Bamford A, et al
     Long-term non-progression in children living with HIV: estimates from international cohort data.
     AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004136.
     PubMed     Abstract available
     
     
     
217. JEENA L, Ferrand RA, Simms V, Kahari C, et al
     Reduced peri-pubertal bone density accrual among Zimbabwean males living with HIV: a longitudinal study.
     AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004134.
     PubMed     Abstract available
     
     
     
218. DIAZ MM, Kamalyan L, Al-Rousan T, Breton J, et al
     Cerebrospinal fluid biomarkers of inflammation and immune activation associated with neurocognitive impairment among U.S. Latinos living with HIV.
     AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004143.
     PubMed     Abstract available
     
     
     
219. SCOFIELD D, Frisch M, Andersson M, Storgaard M, et al
     Physical, psychosocial and sexual health among people aged 50 years and above with and without HIV: a nationwide study.
     AIDS. 2025 Feb 3. doi: 10.1097/QAD.0000000000004140.
     PubMed     Abstract available
     
     
     
220. WAGNER T, Levy I, Wieder-Finesod A, Wax M, et al
     Drug resistance testing at regimen failure in individuals diagnosed with HIV-1 between 2010 and 2018 in Israel.
     AIDS. 2025 Feb 3. doi: 10.1097/QAD.0000000000004138.
     PubMed     Abstract available
     
     
     
221. DIEZ-VIDAL A, Gil-Garrote S, Diaz-Pollan B, Rodriguez-Sevilla G, et al
     Amebic liver abscess presenting in a nonendemic region after a 12-year latency in a patient with well controlled HIV infection.
     AIDS. 2025;39:211-213.
     PubMed    
     
     
     
222. BOWLER SA, Premeaux TA, Ratzan L, Friday C, et al
     Plasma anti-CD4 IgG levels are associated with poor immune recovery in people with HIV initiating antiretroviral therapy.
     AIDS. 2025;39:208-210.
     PubMed     Abstract available
     
     
     
223. GONZALEZ-SCARANO F, Kolson DL
     Imaging brain inflammation in virally suppressed people with HIV-1.
     AIDS. 2025;39:204-205.
     PubMed    
     
     
     January 2025
224. NAIDU N, Kooij KW, Budu M, Ye M, et al
     Exploring the role of sex in hospitalizations among people with and without HIV in British Columbia, Canada.
     AIDS. 2025 Jan 31. doi: 10.1097/QAD.0000000000004135.
     PubMed     Abstract available
     
     
     
225. BROWN MJ, Murtala NM, Amoatika D, Kaur A, et al
     Clinical and sociodemographic characteristics of alzheimer's disease and related dementias (AD/ADRD) among people living with HIV: a cross-sectional analysis.
     AIDS. 2025 Jan 31. doi: 10.1097/QAD.0000000000004137.
     PubMed     Abstract available
     
     
     
226. SPENCER M, Pieri C, Hamzah L, Popoola J, et al
     Antiretroviral therapy in people with HIV and end-stage kidney disease.
     AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004128.
     PubMed     Abstract available
     
     
     
227. URBINA EM, Yu W, Williams PL, Sawyer G, et al
     Central arterial stiffness in young adults with perinatal HIV exposure & infection.
     AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004129.
     PubMed     Abstract available
     
     
     
228. HANTTU AM, Muniandy M, van der Kolk BW, Lindgren H, et al
     Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIV.
     AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004131.
     PubMed     Abstract available
     
     
     
229. XIE X, Fu Y, Gan L, Yang X, et al
     Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study.
     AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004130.
     PubMed     Abstract available
     
     
     
230. BLEICHRODT AM, Okano JT, Fung IC, Chowell G, et al
     The Future of HIV: Challenges in meeting the 2030 Ending the HIV Epidemic in the U.S. (EHE) reduction goal.
     AIDS. 2025 Jan 17. doi: 10.1097/QAD.0000000000004122.
     PubMed     Abstract available
     
     
     
231. BRANTON WG, Zhang N, Cohen EA, Brew BJ, et al
     Brain RNA profiling highlights multiple disease pathways in persons with HAND: uncovering determinants of biotype diversity.
     AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004116.
     PubMed     Abstract available
     
     
     
232. PANG X, Ma J, He Q, Tang K, et al
     Analysis of HIV transmission characteristics and intervention effects in Guangxi based on molecular networks.
     AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004123.
     PubMed     Abstract available
     
     
     
233. PATEL VV, Andrade EA, Zimba R, Mirzayi C, et al
     Preferences for HIV PrEP care among gay, bisexual, and other men who have sex with men: a large discrete choice experiment.
     AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004124.
     PubMed     Abstract available
     
     
     
234. LUCKETT R, Ramogola-Masire D, Zash R, Sears E, et al
     Cervical dysplasia in women with HIV in the modern treat-all era: Elevated risk remains despite long-term ART and normal CD4 count.
     AIDS. 2025 Jan 13. doi: 10.1097/QAD.0000000000004120.
     PubMed     Abstract available
     
     
     
235. DOLLFUS C, Chenadec JL, Reliquet V, Alby-Laurent F, et al
     Outcomes and challenges in adolescents living with HIV in France: a nationwide cohort study over 35 years (1985-2020).
     AIDS. 2025 Jan 13. doi: 10.1097/QAD.0000000000004121.
     PubMed     Abstract available
     
     
     
236. POURCHER V, Robineau O, Parienti JJ, Loubet P, et al
     Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France.
     AIDS. 2025 Jan 10. doi: 10.1097/QAD.0000000000004118.
     PubMed     Abstract available
     
     
     
237. TAVASOLI A, Okwuegbuna OK, Tang B, Iudicello JE, et al
     Hepcidin modifies the relationship between anemia, erythrocyte indices, and neurocognitive performance in virally suppressed people with HIV.
     AIDS. 2025 Jan 7. doi: 10.1097/QAD.0000000000004110.
     PubMed     Abstract available
     
     
     
238. HIDALGO-TENORIO C, Calle-Gomez I, Moya R, Omar M, et al
     Prevalence and incidence of HPV-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people living with HIV (PLHIV).
     AIDS. 2025 Jan 7. doi: 10.1097/QAD.0000000000004113.
     PubMed     Abstract available
     
     
     
239. CASSIDY AR, Mayondi G, Williams PL, Moabi K, et al
     Neurodevelopmental outcomes in children exposed in utero to dolutegravir- or efavirenz-based ART.
     AIDS. 2025 Jan 6. doi: 10.1097/QAD.0000000000004111.
     PubMed     Abstract available
     
     
     
240. VYAS KJ, Marconi VC, Agan BK, Sullivan PS, et al
     Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV.
     AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004105.
     PubMed     Abstract available
     
     
     
241. BOERING P, Murray C, Portwood C, Hey M, et al
     Perinatal outcomes among pregnant women living with HIV initiating antiretroviral therapy preconception and antenatally: systematic review and meta-analysis.
     AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004104.
     PubMed     Abstract available
     
     
     
242. MULINGE MM, Kimani H, Inziani M, Bwana P, et al
     Trends and factors associated with HIV viral load non-suppression among treatment-experienced female sex workers in Kenya: a retrospective cohort study.
     AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004102.
     PubMed     Abstract available
     
     
     
243. WILLIAMS ME, Asia LK, Lindeque Z, Van Vuren EJ, et al
     The relationship between immune markers and tryptophan-kynurenine metabolites in South African people with HIV.
     AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004103.
     PubMed     Abstract available
     
     
     
244. 
     The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV: Erratum.
     AIDS. 2025;39:103.
     PubMed    
     
     
     
245. DO NASCIMENTO AAA, Pasqualotto AC
     Fungal diseases are not in the radar of main international HIV conferences.
     AIDS. 2025;39:99-100.
     PubMed    
     
     
     
246. ALAGARATNAM J, Kelly N, Dustan S, Naous N, et al
     Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirine.
     AIDS. 2025;39:95-98.
     PubMed     Abstract available
     
     
     
247. FUNDERBURG N
     Food insecurity likely contributes to frailty in people with HIV.
     AIDS. 2025;39:93-94.
     PubMed    
     
     
     
248. GUARALDI G, Winslow DL, Raggi P
     REPRIEVE informs on kidney disease in people with HIV.
     AIDS. 2025;39:91-92.
     PubMed    
     
     
     
249. BRUGUERA A, Nomah DK, Moreno-Fornes S, Martinez E, et al
     Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands.
     AIDS. 2025;39:64-74.
     PubMed     Abstract available
     
     
     
250. BONACINA S, Lichtenstein JD, Niemczak CE, Magohe A, et al
     The relationship between HIV and reading performance for children in Tanzania.
     AIDS. 2025;39:49-56.
     PubMed     Abstract available
     
     
     
251. VANPOUILLE C, Wells A, DeGruttola V, Lynch M, et al
     Cytokine trajectory over time in men and women with HIV on long-term antiretroviral therapy.
     AIDS. 2025;39:1-10.
     PubMed     Abstract available
     
     
     December 2024
252. BILLOCK RM, France AM, Saduvala N, Panneer N, et al
     Contribution of HIV transmission bursts to future HIV infections, United States.
     AIDS. 2024 Dec 24. doi: 10.1097/QAD.0000000000004101.
     PubMed     Abstract available
     
     
     
253. VAN ZYL GU, Jennings L, Rabie H, Orrell C, et al
     Dolutegravir regimens have transformed treatment but ongoing drug resistance research is required to maintain success.
     AIDS. 2024 Dec 23. doi: 10.1097/QAD.0000000000004099.
     PubMed    
     
     
     
254. RUDERMAN SA, Nance RM, Crane HM, Cachay E, et al
     Cumulative HIV viral load and lower CD4 cell count are associated with incident venous thromboembolism in people with HIV.
     AIDS. 2024 Dec 18. doi: 10.1097/QAD.0000000000004095.
     PubMed     Abstract available
     
     
     
255. ELF JL, Lebina L, Motlhaoleng K, Chon S, et al
     A randomized trial for combination nicotine replacement therapy for smoking cessation among people with HIV in a low-resourced setting.
     AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004093.
     PubMed     Abstract available
     
     
     
256. MIGAUD P, Pria AD, Hosmann K, Kellerher P, et al
     Hemophagocytic lymphohistiocytosis in HIV-associated HHV8-positive multicentric castleman disease.
     AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004094.
     PubMed     Abstract available
     
     
     
257. MATTHEWS LT, Bruxvoort KJ, Jaggernath M, Kriel Y, et al
     Use of tenofovir-based PrEP among pregnant women in South Africa.
     AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004090.
     PubMed     Abstract available
     
     
     
258. LIU B, Zhang Q
     Association between CD4 count, CD4/CD8 ratio, and fragility fractures in people living with HIV: a retrospective cohort study in China.
     AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004091.
     PubMed     Abstract available
     
     
     
259. WANG C, Letendre SL, Hong S, Andalibi M, et al
     Differential systemic immune-inflammation index levels in people with and without HIV infection.
     AIDS. 2024 Dec 13. doi: 10.1097/QAD.0000000000004088.
     PubMed     Abstract available
     
     
     
260. WANG T, Xu Y, Zhou S, Zhang X, et al
     Associations between salivary microbiota and KSHV infection in people with HIV: a cross-sectional study in ili prefecture, Xinjiang, China.
     AIDS. 2024 Dec 11. doi: 10.1097/QAD.0000000000004087.
     PubMed     Abstract available
     
     
     
261. WEISSER M, Mapesi H, Vanobberghen F, Okuma J, et al
     Body weight changes in people living with HIV starting dolutegravir versus efavirenz-based regimens in a large cohort in rural Tanzania.
     AIDS. 2024 Dec 4. doi: 10.1097/QAD.0000000000004085.
     PubMed     Abstract available
     
     
     
262. IRIARTE E, Smyth HL, Schmiege S, Tassiopoulos K, et al
     Predictors of frailty trajectories among people with HIV.
     AIDS. 2024 Dec 3. doi: 10.1097/QAD.0000000000004086.
     PubMed     Abstract available
     
     
     
263. DREYER AJ, Le Roux C, Gf Thomas K, Sabin CA, et al
     Psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIV.
     AIDS. 2024 Dec 2. doi: 10.1097/QAD.0000000000004080.
     PubMed     Abstract available
     
     
     
264. YEE LM, Powis KM, Jao J, Haddad LB, et al
     Substance use during pregnancy and postpartum among individuals with perinatally-acquired HIV in the United States.
     AIDS. 2024;38:2103-2107.
     PubMed     Abstract available
     
     
     
265. BERING L, Heftdal LD, Heidari SL, Hamm SR, et al
     Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes.
     AIDS. 2024;38:2100-2103.
     PubMed     Abstract available
     
     
     
266. PARASKEVIS D, Masenga SK
     Self-collected or staff-collected dried blood spot specimens for HIV-1 viral load testing.
     AIDS. 2024;38:2098-2099.
     PubMed    
     
     
     
267. SALVANA EMT, Martinez E
     Still losing sleep over HIV.
     AIDS. 2024;38:2096-2097.
     PubMed    
     
     
     
268. BOLZENIUS J, Agan BK
     Mitigating cognitive impairment in people with HIV by targeting potential impacts of toxoplasmic infection.
     AIDS. 2024;38:2093-2095.
     PubMed    
     
     
     
269. MAZZITELLI M, Trunfio M, Scaglione V, Sasset L, et al
     Multidimensional program for insomnia in a cohort of people with HIV.
     AIDS. 2024;38:2040-2049.
     PubMed     Abstract available
     
     
     November 2024
270. LI W, Li G, Liu Y, Meng L, et al
     Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection.
     AIDS. 2024 Nov 29. doi: 10.1097/QAD.0000000000004079.
     PubMed     Abstract available
     
     
     
271. HE B, Chen S, Yang X, Olatosi B, et al
     Association between substance use disorders and sustained viral suppression: a longitudinal analysis among people with HIV in South Carolina.
     AIDS. 2024 Nov 28. doi: 10.1097/QAD.0000000000004077.
     PubMed     Abstract available
     
     
     
272. SUKUMARAN L, Sabin CA, Kunisaki KM, Doyle N, et al
     Associations between multimorbidity burden and objective and patient-reported sleep outcomes among people living with HIV.
     AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004073.
     PubMed     Abstract available
     
     
     
273. LESKO CR, Fojo AT, Hutton HE, Falade-Nwulia OO, et al
     The effect of antidepressant treatment on viral suppression among people with HIV diagnosed with depression in an urban clinic, 2012-2023.
     AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004074.
     PubMed     Abstract available
     
     
     
274. BAQUERO L, Stover S, Armani Tourret M, Perbelis A, et al
     Differential immunophenotype and proviral composition in young adults with perinatally acquired HIV: Are special cure strategies needed?
     AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004075.
     PubMed     Abstract available
     
     
     
275. PAULSEN FW, Tetens MM, Gerstoft J, Kronborg G, et al
     Use of non-barrier contraceptives among women with human immunodeficiency virus; a nationwide, matched cohort study.
     AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004067.
     PubMed     Abstract available
     
     
     
276. BROMBERG DJ, Rhoades D, Madden LM, Ivasiy R, et al
     Transformation of the HIV treatment cascade for people who inject drugs in Ukraine.
     AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004056.
     PubMed     Abstract available
     
     
     
277. GUPTA SK, Friedman AN, Desta Z
     The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysis.
     AIDS. 2024 Nov 25. doi: 10.1097/QAD.0000000000004071.
     PubMed     Abstract available
     
     
     
278. PAPOT E, Tovar-Sanchez T, Woods J, Thaurignac G, et al
     SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa.
     AIDS. 2024 Nov 22. doi: 10.1097/QAD.0000000000004068.
     PubMed     Abstract available
     
     
     
279. FILIP I
     The case for integrating menopause care and HIV management.
     AIDS. 2024 Nov 22. doi: 10.1097/QAD.0000000000004069.
     PubMed    
     
     
     
280. AUGELLO M, Bono V, Rovito R, Santoro A, et al
     Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV.
     AIDS. 2024;38:1987-1990.
     PubMed     Abstract available
     
     
     
281. LUISA MONTES M, Busca C, Rava M, Bernardino JI, et al
     Hepatic steatosis-insulin resistance and type 2 diabetes in people with HIV at diagnosis: effect of initial antiretroviral therapy.
     AIDS. 2024;38:1982-1987.
     PubMed     Abstract available
     
     
     
282. SHERER R, Simon GL
     Do women with HIV, diabetes mellitus, and full antiretroviral therapy adherence have a lower rate of HIV viremia than men?
     AIDS. 2024;38:1980-1981.
     PubMed    
     
     
     
283. MASENGA SK, Bernardino JI
     Binge eating correlates with weight excess in people with HIV.
     AIDS. 2024;38:1978-1979.
     PubMed    
     
     
     
284. YAN LD, Rouzier V, Sufra R, Sauveur RST, et al
     Treatment of prehypertension among adults with HIV: a randomized clinical trial.
     AIDS. 2024 Nov 14. doi: 10.1097/QAD.0000000000004065.
     PubMed     Abstract available
     
     
     
285. DOS SANTOS AP, Willig AL, Ruderman S, Oliveira VHF, et al
     Hazardous alcohol consumption is associated with an increased occurrence of falls among people with HIV in the PROSPER-HIV Study.
     AIDS. 2024 Nov 11. doi: 10.1097/QAD.0000000000004061.
     PubMed     Abstract available
     
     
     
286. NOVITSKY V, Steingrimsson J, Guang A, Dunn CW, et al
     Dynamics of clustering rates in the rhode Island HIV-1 epidemic.
     AIDS. 2024 Nov 11. doi: 10.1097/QAD.0000000000004062.
     PubMed     Abstract available
     
     
     
287. VONDER TW, Mudrikova T
     Higher non-HIV-comorbidity burden in long-term survivors.
     AIDS. 2024 Nov 6. doi: 10.1097/QAD.0000000000004054.
     PubMed     Abstract available
     
     
     
288. FRIEDMAN MR, Wingood G, Krause KD, Krier S, et al
     Medical mistrust and vaccine-hesitant attitudes explain SARS-CoV-2 vaccination disparities in a mixed-serostatus cohort.
     AIDS. 2024 Nov 5. doi: 10.1097/QAD.0000000000004053.
     PubMed     Abstract available
     
     
     
289. CUI Y, Moyo S, Pretorius Holme M, Hurwitz KE, et al
     Predictors of HIV seroconversion in Botswana: machine learning analysis in a representative, population-based HIV incidence cohort.
     AIDS. 2024 Nov 4. doi: 10.1097/QAD.0000000000004055.
     PubMed     Abstract available
     
     
     
290. GOLDBERG RL, Peterson TE, Haberlen SA, Witt MD, et al
     Response to "Epicardial fat tissue and diastolic dysfunction in both men and women with HIV".
     AIDS. 2024;38:1895.
     PubMed    
     
     
     
291. HAN WM, Apornpong T, Tumkosit M, Avihingsanon A, et al
     Epicardial fat tissue and diastolic dysfunction in both men and women with HIV.
     AIDS. 2024;38:1893-1894.
     PubMed    
     
     
     
292. MUCCINI C, Gianotti N, Lolatto R, Nozza S, et al
     CD4+/CD8+ improvement after switch from a second-generation integrase inhibitor regimen to long-acting cabotegravir and rilpivirine.
     AIDS. 2024;38:1890-1892.
     PubMed     Abstract available
     
     
     
293. MARTINEZ E, Dorfman D
     Addressing methamphetamine use in persons with HIV.
     AIDS. 2024;38:1888-1889.
     PubMed    
     
     
     
294. GOODKIN K, Winston A, Martinez E, Paul R, et al
     Anticholinergic and sedative medication use in persons with HIV: defining the evidence for risks on cognition.
     AIDS. 2024;38:1885-1887.
     PubMed    
     
     
     October 2024
295. SUVADA K, Kocher E, Diwan N, Nagy A, et al
     Incidence of high blood pressure among Kenyan adults living with HIV: a longitudinal cohort analysis from 2004-2023.
     AIDS. 2024 Oct 29. doi: 10.1097/QAD.0000000000004050.
     PubMed     Abstract available
     
     
     
296. VOLLMOND CV, Tetens MM, Gerstoft J, Kronborg G, et al
     Bipolar disorder in people with HIV: A nationwide, population-based matched case-control and matched cohort study.
     AIDS. 2024 Oct 29. doi: 10.1097/QAD.0000000000004049.
     PubMed     Abstract available
     
     
     
297. ENI-OLUTU A, Mackie NE, Glenn J, Bailey A, et al
     Emerging integrase resistance in an international perinatal virtual clinic.
     AIDS. 2024 Oct 28. doi: 10.1097/QAD.0000000000004048.
     PubMed     Abstract available
     
     
     
298. CHAISSON LH, Durovni B, Umar N, Cohn S, et al
     Sex differences in tuberculosis infection and disease among people with HIV.
     AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004045.
     PubMed     Abstract available
     
     
     
299. VERGORI A, Del Duca G, Lorenzini P, Brita AC, et al
     Impact of switching from EFV/F/TDF to B/F/TAF on psychiatric symptoms and neurocognition.
     AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004043.
     PubMed     Abstract available
     
     
     
300. RUDERMAN SA, Hunt PW, Beck-Engeser G, Ambayec G, et al
     Biomarkers of microbial translocation and generalized inflammation are associated with frailty among people with HIV.
     AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004047.
     PubMed     Abstract available
     
     
     
301. DUONG KNC, Schmutz HW, Ben-Umeh KC, Duru EE, et al
     Real-world clinical and economic outcomes from rapid start antiretroviral therapy in HIV: systematic review and meta-analysis.
     AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004046.
     PubMed     Abstract available
     
     
     
302. SOCIO GV, Ricci E, Piconi S, Squillace N, et al
     Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort.
     AIDS. 2024 Oct 22. doi: 10.1097/QAD.0000000000004042.
     PubMed     Abstract available
     
     
     
303. OLIVERO R, Williams PL, Sawyer G, Yee LM, et al
     Birth outcomes following bictegravir exposure during pregnancy.
     AIDS. 2024 Oct 15. doi: 10.1097/QAD.0000000000004041.
     PubMed     Abstract available
     
     
     
304. SUMNER T, Clark RA, Prys-Jones TO, Bakker R, et al
     The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa.
     AIDS. 2024 Oct 11. doi: 10.1097/QAD.0000000000004038.
     PubMed     Abstract available
     
     
     
305. RUBIN LH, Maki PM, Du Y, Sweeney SE, et al
     Imaging the translocator protein 18 kDa within cognitive control and declarative memory circuits in virally-suppressed people with HIV.
     AIDS. 2024 Oct 11. doi: 10.1097/QAD.0000000000004034.
     PubMed     Abstract available
     
     
     
306. HEFFRON R, Muwonge TR, Thomas KK, Zewdie K, et al
     Bone density changes in young women in Uganda using tenofovir-based HIV pre-exposure prophylaxis and depot medroxyprogesterone acetate contraception.
     AIDS. 2024 Oct 9. doi: 10.1097/QAD.0000000000004029.
     PubMed     Abstract available
     
     
     
307. HEY M, Thompson L, Portwood C, Sexton H, et al
     Adverse perinatal outcomes associated with different classes of antiretroviral drugs in pregnant women living with HIV: a systematic review and meta-analysis.
     AIDS. 2024 Oct 8. doi: 10.1097/QAD.0000000000004032.
     PubMed     Abstract available
     
     
     
308. FILIP I
     Person-centered pre-exposure prophylaxis: the next wave of innovation in HIV prevention.
     AIDS. 2024 Oct 7. doi: 10.1097/QAD.0000000000004030.
     PubMed    
     
     
     
309. SIREGAR T, Weriditi RK, Reba YA, Muttaqin MZ, et al
     Impact of COVID-19 vaccination on HIV parameters in people with HIV on antiretroviral therapy.
     AIDS. 2024;38:1807-1808.
     PubMed    
     
     
     
310. CLEMENTE T, Pontillo D, Malagnino V, Calza L, et al
     Cancer in people with multidrug-resistant HIV.
     AIDS. 2024;38:1801-1806.
     PubMed     Abstract available
     
     
     
311. LEAL M, Kerr L, Mota RMS, Motta-Castro ARC, et al
     Increasing HIV prevalence rate among men who have sex with men: results of a comparison of two national surveys.
     AIDS. 2024;38:1799-1801.
     PubMed     Abstract available
     
     
     
312. GOUVEA-E-SILVA LF
     Challenges in clinical monitoring of people with HIV: evolution from prediabetes mellitus to diabetes mellitus.
     AIDS. 2024;38:1796-1798.
     PubMed    
     
     
     
313. NICOL MR, Dawood H, Hoy JF
     Deconvoluting the contribution of antiretroviral choice in weight gain.
     AIDS. 2024;38:1794-1795.
     PubMed    
     
     
     September 2024
314. WIJSTMA E, Jongen VW, Boyd A, de Vries HJC, et al
     Outcomes of a policy to prioritize populations with expected healthcare barriers for subsidized PrEP care in Amsterdam, the Netherlands: a cross-sectional study.
     AIDS. 2024 Sep 30. doi: 10.1097/QAD.0000000000004027.
     PubMed     Abstract available
     
     
     
315. PASTORI D, Del Sole F, Brogi T, Del Ben M, et al
     Epicardial fat and liver stiffness by ARFI elastography in people living with Human Immunodeficiency Virus type 1 (HIV-1) infection without liver disease.
     AIDS. 2024 Sep 30. doi: 10.1097/QAD.0000000000004028.
     PubMed     Abstract available
     
     
     
316. BROCHON J, Ducruet T, Taillefer S, Lamarre V, et al
     Increased risk of hospitalization among children who were HIV-exposed and uninfected compared to population controls.
     AIDS. 2024 Sep 27. doi: 10.1097/QAD.0000000000004025.
     PubMed     Abstract available
     
     
     
317. REID MJA, Bunnell R, Davis M, Carter H, et al
     Sustaining two decades of PEPFAR's response to global HIV/AIDS: mitigating the impact of climate threats.
     AIDS. 2024 Sep 23. doi: 10.1097/QAD.0000000000004023.
     PubMed    
     
     
     
318. LAM JO, Hou CE, Lee C, Samiezade-Yazd Z, et al
     Hypertension control and risk of age-associated dementia in people with hiv infection.
     AIDS. 2024 Sep 18. doi: 10.1097/QAD.0000000000004017.
     PubMed     Abstract available
     
     
     
319. YADAV A, Gionet G, Karaj A, Kossenkov AV, et al
     Association of smoking with neurocognition, inflammatory and myeloid cell activation profiles in people with HIV on ART.
     AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004015.
     PubMed     Abstract available
     
     
     
320. UELAND T, Nkele I, Hoel H, Lockman S, et al
     Markers of extracellular matrix degradation and inflammasome activation are associated with carotid plaques in virally suppressed people with HIV in Botswana.
     AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004014.
     PubMed     Abstract available
     
     
     
321. FILIP I
     Twice-yearly lenacapavir may change the standard of HIV prevention for women.
     AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004013.
     PubMed    
     
     
     
322. OVERTON ET, Kantor A, Fitch KV, Mosepele M, et al
     Proteinuria and albuminuria among a global primary CVD prevention cohort of PWH: prevalence and associated factors.
     AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004016.
     PubMed     Abstract available
     
     
     
323. SAHU M, Schaafsma T, Szpiro AA, Van Rooyen H, et al
     Performance of patient-collected dried blood spot specimens for HIV-1 viral load testing: evidence from the DO ART Study in South Africa.
     AIDS. 2024 Sep 13. doi: 10.1097/QAD.0000000000004011.
     PubMed     Abstract available
     
     
     
324. KUNIHOLM MH, Murenzi G, Shumbusho F, Brazier E, et al
     Association of cardiovascular disease risk with liver steatosis and fibrosis in people living with hiv in low- and middle-income countries.
     AIDS. 2024 Sep 12. doi: 10.1097/QAD.0000000000004012.
     PubMed     Abstract available
     
     
     
325. CUMMINGS TH, Magagnoli J, Sikirzhytskaya S, Tyagin I, et al
     Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among People Living with HIV.
     AIDS. 2024 Sep 10. doi: 10.1097/QAD.0000000000004009.
     PubMed     Abstract available
     
     
     
326. ZANIEWSKI E, Skrivankova VW, Brazier E, Avihingsanon A, et al
     Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics.
     AIDS. 2024 Sep 5. doi: 10.1097/QAD.0000000000004007.
     PubMed     Abstract available
     
     
     
327. RUDERMAN SA, Willig AL, Cleveland JD, Burkholder G, et al
     Low food security is associated with frailty status and frailty components among people with HIV.
     AIDS. 2024 Sep 4. doi: 10.1097/QAD.0000000000004006.
     PubMed     Abstract available
     
     
     
328. EUSTAQUIO PC, Burnett J, Prejean J, Chapin-Bardales J, et al
     Changes in HIV Pre-exposure Prophylaxis Awareness and Use Among Males Who Inject Drugs Who Have Sex with Men by Sexual Identity, 19 US Urban Areas, 2018 & 2022.
     AIDS. 2024 Sep 3. doi: 10.1097/QAD.0000000000004005.
     PubMed     Abstract available
     
     
     
329. ZHAO R, Sanstead E, Alarid-Escudero F, Huchko M, et al
     Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study.
     AIDS. 2024 Sep 2. doi: 10.1097/QAD.0000000000004002.
     PubMed     Abstract available
     
     
     
330. FILIP I
     Perinatal exposure to HIV leaves a lasting neurocognitive mark - even when vertical transmission is prevented.
     AIDS. 2024 Sep 2. doi: 10.1097/QAD.0000000000004004.
     PubMed    
     
     
     
331. BURGER D, Wttewaal E, Oosterhof P, Stalenhoef J, et al
     Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance.
     AIDS. 2024;38:1728-1729.
     PubMed    
     
     
     
332. PRYKE LA, Liu Z, Khaitan AK, Sims EK, et al
     Immune checkpoints and pancreatic beta cell dysfunction in HIV.
     AIDS. 2024;38:1725-1727.
     PubMed     Abstract available
     
     
     
333. TREVILLYAN JM, Dart A, Paul E, Dewar EM, et al
     Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk.
     AIDS. 2024;38:1722-1724.
     PubMed     Abstract available
     
     
     
334. MUCHAILI L, Masenga SK
     Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV.
     AIDS. 2024;38:1720-1721.
     PubMed    
     
     
     August 2024
335. TARAMASSO L, Dentone C, Cama I, Fenoglio D, et al
     Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV.
     AIDS. 2024 Aug 30. doi: 10.1097/QAD.0000000000004001.
     PubMed     Abstract available
     
     
     
336. NEARY J, Chebet D, Benki-Nugent S, Moraa H, et al
     Association between HIV and cytomegalovirus and neurocognitive outcomes among children with HIV.
     AIDS. 2024 Aug 29. doi: 10.1097/QAD.0000000000004000.
     PubMed     Abstract available
     
     
     
337. CRAWFORD TN, Neilands TB, Drumright LN, Fredericksen RJ, et al
     Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support.
     AIDS. 2024 Aug 29. doi: 10.1097/QAD.0000000000003999.
     PubMed     Abstract available
     
     
     
338. HYBEL TE, Sorensen EF, Enemark MH, Hemmingsen JK, et al
     Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes.
     AIDS. 2024 Aug 22. doi: 10.1097/QAD.0000000000003996.
     PubMed     Abstract available
     
     
     
339. CAPELL-MORELL M, Bradbury M, Dinares MC, Hernandez J, et al
     Anal high-grade intraepithelial neoplasia and cancer in women living with HIV and HIV-negative women with other risk factors.
     AIDS. 2024 Aug 14. doi: 10.1097/QAD.0000000000003995.
     PubMed     Abstract available
     
     
     
340. DIAZ MM, Mccutchan JA, Crescini M, Tang B, et al
     Longitudinal Study of Cognitive Function in People with HIV and Toxoplasmic Encephalitis or Latent toxoplasma Infection.
     AIDS. 2024 Aug 9. doi: 10.1097/QAD.0000000000003992.
     PubMed     Abstract available
     
     
     
341. SILVA MS, Torres TS, Coutinho C, Jalil EM, et al
     Mpox, sexually transmitted infections and combination prevention: insights from a major cohort in Rio de Janeiro, Brazil.
     AIDS. 2024 Aug 9. doi: 10.1097/QAD.0000000000003991.
     PubMed     Abstract available
     
     
     
342. FILIP I
     Uneven progress in reducing mortality in people with HIV underscores the need for interventions focused on vulnerable populations.
     AIDS. 2024 Aug 9. doi: 10.1097/QAD.0000000000003993.
     PubMed    
     
     
     
343. PATEL PB, Prince DK, Bolenzius J, Chen P, et al
     Medical comorbidities and lower myelin content are associated with poor cognition in young adults with perinatally acquired HIV.
     AIDS. 2024 Aug 7. doi: 10.1097/QAD.0000000000003989.
     PubMed     Abstract available
     
     
     
344. ALDREDGE A, Mehta CC, Lahiri CD, Schneider MF, et al
     Consequences of low-level viremia among women with HIV in the United States from 2003 - 2020.
     AIDS. 2024 Aug 7. doi: 10.1097/QAD.0000000000003990.
     PubMed     Abstract available
     
     
     
345. ZEWDIE K, Muwonge T, Ssebuliba T, Bambia F, et al
     A point-of-care tenofovir urine test improves accuracy of self-reported PrEP adherence and increases condomless sex reporting among young women.
     AIDS. 2024 Aug 2. doi: 10.1097/QAD.0000000000003988.
     PubMed     Abstract available
     
     
     
346. 
     Initial antiretroviral therapy regimen and risk of heart failure: Erratum.
     AIDS. 2024;38:1608.
     PubMed    
     
     
     
347. 
     Dolutegravir-induced neural tube defects in mice are folate responsive: Erratum.
     AIDS. 2024;38:1607.
     PubMed    
     
     
     
348. 
     The association between anticholinergic/sedative burden and physical frailty in people aging with HIV: Erratum.
     AIDS. 2024;38:1606.
     PubMed    
     
     
     
349. ELAHI S
     Galectin-9, a lingering shadow in HIV's fight: the unseen battle of adolescents with perinatally-acquired HIV.
     AIDS. 2024;38:1589-1591.
     PubMed    
     
     
     
350. KOHLER P, Larsen A, Abuna F, Owiti G, et al
     Patient actor training improves preexposure prophylaxis delivery for adolescent girls and young women in Kenya: a cluster randomized trial.
     AIDS. 2024;38:1505-1512.
     PubMed     Abstract available
     
     
     
351. ZALLA LC, Hutton HE, Fojo AT, Falade-Nwulia OO, et al
     The anxiety care continuum and its association with viral suppression among persons with HIV.
     AIDS. 2024 Aug 1. doi: 10.1097/QAD.0000000000003986.
     PubMed     Abstract available
     
     
     
352. HURCHUND R, Sibiya SE, Owaga BO, Owira PMO, et al
     Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats.
     AIDS. 2024 Aug 1. doi: 10.1097/QAD.0000000000003987.
     PubMed     Abstract available
     
     
     
353. BOZZI G, Centazzo M, Scaglioni S, Butta GM, et al
     Primary HIV infection during chronic treatment with imatinib: impact on infection dynamics.
     AIDS. 2024;38:1601-1604.
     PubMed    
     
     
     
354. CHAMBERS C, Cooper CL, Kroch AE, Buchan SA, et al
     Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves.
     AIDS. 2024;38:1597-1600.
     PubMed     Abstract available
     
     
     
355. LINFIELD RY, Slusky DJG, Moskatel LS
     The impact of Mpox virus incidence and Mpox virus first-dose vaccination on recent HIV testing.
     AIDS. 2024;38:1595-1597.
     PubMed     Abstract available
     
     
     July 2024
356. MANJI KP, Muhihi A, Duggan CP, Alwy Al-Beity FM, et al
     Fetal, neonatal, and infant death among offspring of pregnant women living with HIV in Tanzania.
     AIDS. 2024 Jul 31. doi: 10.1097/QAD.0000000000003985.
     PubMed     Abstract available
     
     
     
357. KAMPOURI E, Damas J, Kusejko K, Ledergerber B, et al
     Prevalence of HIV-related stigma among people with HIV in Switzerland: addressing the elephant in the room.
     AIDS. 2024 Jul 25. doi: 10.1097/QAD.0000000000003983.
     PubMed     Abstract available
     
     
     
358. MANN SC, Tong W, Abraham AG, Palella F, et al
     The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study.
     AIDS. 2024 Jul 19. doi: 10.1097/QAD.0000000000003978.
     PubMed     Abstract available
     
     
     
359. STONER MCD, Kelly NK, Gomez-Olive FX, Mall S, et al
     Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa: A HPTN 068 case cohort study.
     AIDS. 2024 Jul 18. doi: 10.1097/QAD.0000000000003981.
     PubMed     Abstract available
     
     
     
360. DUFFY CR, Herlihy JM, Zulu E, Mwananyanda L, et al
     Preterm birth among women living with HIV: impact of preconception cART initiation.
     AIDS. 2024 Jul 17. doi: 10.1097/QAD.0000000000003979.
     PubMed     Abstract available
     
     
     
361. TEJEDOR MT, Rial-Crestelo D, Diab L, de Lagarde M, et al
     Fibrocavitary disease caused by Mycobacterium chimaera in a patient with HIV.
     AIDS. 2024;38:1446-1448.
     PubMed    
     
     
     
362. CAMPBELL L, Barbini B, Cromarty B, Hamzah L, et al
     Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxil.
     AIDS. 2024;38:1442-1445.
     PubMed     Abstract available
     
     
     
363. JOHNSON AT, Ntloedibe T, Mendez Reyes JE, Matshaba MS, et al
     Impact of efavirenz on hormone-positive breast cancer survival in women living with HIV.
     AIDS. 2024;38:1439-1442.
     PubMed     Abstract available
     
     
     
364. MATHUR P, Ramadhani HO, Kaplan R, Stafford KA, et al
     Interferon-free hepatitis C treatment increases a surrogate of atherosclerotic cardiovascular disease risk in Black veterans living with HIV.
     AIDS. 2024;38:1437-1439.
     PubMed     Abstract available
     
     
     
365. MATSENA-ZINGONI Z, Blower S
     Successful control of HIV in sub-Saharan Africa is causing a new problem.
     AIDS. 2024;38:1435-1436.
     PubMed    
     
     
     
366. MAUSS S, Stapleton JT, Thomas DL
     Steatotic liver disease progression in persons with HIV: weighting for answers.
     AIDS. 2024;38:1432-1434.
     PubMed    
     
     
     
367. HILL AM, Elbirt D
     Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial.
     AIDS. 2024;38:1430-1431.
     PubMed    
     
     
     
368. YAN Y, Yuan R, Deng L, Hu H, et al
     The construction of a novel supplementary diagnostic model for patients with indeterminate HIV infection: a proteomics study.
     AIDS. 2024 Jul 15. doi: 10.1097/QAD.0000000000003977.
     PubMed     Abstract available
     
     
     
369. BAMFORD L, Rajagopal A, Grelotti D, Justice-Royster V, et al
     Impact of methamphetamine use on HIV and other health outcomes at an urban HIV medicine clinic.
     AIDS. 2024 Jul 3. doi: 10.1097/QAD.0000000000003975.
     PubMed     Abstract available
     
     
     
370. WILLIAMS LD, van Heerden A, Friedman SR, Chibi B, et al
     Comparison of a novel expanded social network recruitment intervention with risk network recruitment to HIV testing: locating undiagnosed cases in South Africa.
     AIDS. 2024 Jul 3. doi: 10.1097/QAD.0000000000003976.
     PubMed     Abstract available
     
     
     
371. SILHOL R, Maheu-Giroux M, Soni N, Fotso AS, et al
     The impact of past HIV interventions and diagnosis gaps on new HIV acquisitions, transmissions, and HIV-related deaths in Cote d'Ivoire, Mali, and Senegal.
     AIDS. 2024 Jul 2. doi: 10.1097/QAD.0000000000003974.
     PubMed     Abstract available
     
     
     
372. KING EM, Tkachuk S, Tseng A
     Aging on Antiretrovirals: Reviewing the need for pharmacologic data in elderly people living with HIV.
     AIDS. 2024 Jul 2. doi: 10.1097/QAD.0000000000003973.
     PubMed    
     
     
     
373. 
     Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals: Erratum.
     AIDS. 2024;38:1280.
     PubMed    
     
     
     
374. 
     Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV: Erratum.
     AIDS. 2024;38:1279.
     PubMed    
     
     
     
375. DE S CARVALHO R, Rangel IC, Ferry FRA
     Towards a refined understanding of cerebrospinal fluid CXCL13 in neurosyphilis diagnosis among people with HIV.
     AIDS. 2024;38:1275-1278.
     PubMed    
     
     
     
376. TRUNFIO M, Bonora S, di Perri G, Calcagno A, et al
     Further considerations on the use of cerebrospinal fluid C-X-C motif chemokine ligand 13 in the diagnosis of neurosyphilis among people with HIV.
     AIDS. 2024;38:1273-1275.
     PubMed    
     
     
     
377. KARABAY O
     Concerns and clarifications regarding the article 'Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first line ART regimen in Zimbabwe'.
     AIDS. 2024;38:1273.
     PubMed    
     
     
     
378. LEROY P, Diamantis S, Sellier PO, Hamet G, et al
     Prescriptions of generic antiretroviral drugs in three healthcare centers in the Paris area, France.
     AIDS. 2024;38:1269-1272.
     PubMed     Abstract available
     
     
     
379. RUBENSTEIN E, Diemer M, Goldwirt L, Lascoux-Combe C, et al
     Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine.
     AIDS. 2024;38:1267-1269.
     PubMed     Abstract available
     
     
     
380. ABDEL-HAMEED EA, Masenga SK
     HIV-related gut damage persists long-term in perinatally acquired HIV and is associated with insulin resistance.
     AIDS. 2024;38:1265-1266.
     PubMed    
     
     
     
381. WINSLOW DL
     Is early initiation of antiretroviral therapy important?
     AIDS. 2024;38:1263-1264.
     PubMed    
     
     
     
382. MOOLLA H, Davies MA, Davies C, Euvrard J, et al
     The effect of care interruptions on mortality in adults resuming antiretroviral therapy.
     AIDS. 2024;38:1198-1205.
     PubMed     Abstract available
     
     
     June 2024
383. GRAM EJPN, Moseholm E, Norlov AB, Wilken-Jensen C, et al
     Cervical cancer screening integrated in routine clinical care of women living with HIV.
     AIDS. 2024 Jun 28. doi: 10.1097/QAD.0000000000003972.
     PubMed     Abstract available
     
     
     
384. WU C, Xu X, Peng C, Lou Z, et al
     Cost-effectiveness of different intervention strategies of human immunodeficiency virus in Zhejiang, China: a Model Study From 2023 to 2052.
     AIDS. 2024 Jun 26. doi: 10.1097/QAD.0000000000003968.
     PubMed     Abstract available
     
     
     
385. MASTERS MC, Tassiopoulos K, Bao Y, Wu K, et al
     Risk factors for progression from prediabetes to diabetes among older persons with HIV.
     AIDS. 2024 Jun 26. doi: 10.1097/QAD.0000000000003970.
     PubMed     Abstract available
     
     
     
386. MARTINSON T, Montoya R, Moreira C, Kuncze K, et al
     Point-of-care urine tenofovir test predicts future HIV pre-exposure prophylaxis discontinuation among young users.
     AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003962.
     PubMed     Abstract available
     
     
     
387. KING JM, Dobbins T, Keen P, Cornelisse VJ, et al
     Trends in HIV testing and HIV stage at diagnosis among people newly diagnosed with HIV.
     AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003961.
     PubMed     Abstract available
     
     
     
388. YOTEBIENG M, Zotova N, Bernard C, Goodrich S, et al
     Accuracy of PHQ-9 against psychiatric diagnosis for depression among people living with HIV: A multicounty cross-sectional study.
     AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003963.
     PubMed     Abstract available
     
     
     
389. MICHAEL HU, Brouillette MJ, Tamblyn R, Fellows LK, et al
     Cognitive impact of anticholinergic and sedative burden in people living with HIV.
     AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003966.
     PubMed     Abstract available
     
     
     
390. ROSE PC, Davies C, Cotton MF, Otwombe K, et al
     Longitudinal controlled attenuation parameter and liver stiffness in children with and without perinatal HIV infection in South Africa.
     AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003964.
     PubMed     Abstract available
     
     
     
391. SCHNITTMAN SR, Talathi R, Wilks MQ, Hedgire S, et al
     Association of T-cell subtypes with macrophage-specific arterial infiltration in PWH.
     AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003967.
     PubMed     Abstract available
     
     
     
392. RUSSO SC, Ockene MW, Arpante AK, Johnson JE, et al
     Efficacy and safety of tesamorelin in people with hiv on integrase inhibitors.
     AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003965.
     PubMed     Abstract available
     
     
     
393. BLAIR J, Kempf MC, Dionne JA, Causey-Pruitt Z, et al
     Awareness, treatment, and control of hypertension among women at risk or living with HIV in the US South: a prospective study.
     AIDS. 2024 Jun 20. doi: 10.1097/QAD.0000000000003960.
     PubMed     Abstract available
     
     
     
394. FILIP I
     Decoding the effects of statins on cardiovascular risk: are we closer to better risk-prediction tools for people with HIV?
     AIDS. 2024 Jun 19. doi: 10.1097/QAD.0000000000003958.
     PubMed    
     
     
     
395. SODEKE O, Milligan K, Ezeuko I, Oladipo A, et al
     Longitudinal viral load outcomes of adults with HIV after detectable viremia on tenofovir, lamivudine, and dolutegravir.
     AIDS. 2024 Jun 13. doi: 10.1097/QAD.0000000000003956.
     PubMed     Abstract available
     
     
     
396. FUNG K, Hernandez-Diaz S, Zash R, Chadwick EG, et al
     First-trimester exposure to newer antiretroviral agents and congenital anomalies in a U.S. cohort.
     AIDS. 2024 Jun 12. doi: 10.1097/QAD.0000000000003955.
     PubMed     Abstract available
     
     
     
397. HWANG YJ, Lesko CR, Brown TT, Alexander GC, et al
     Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV: a longitudinal cohort study.
     AIDS. 2024 Jun 12. doi: 10.1097/QAD.0000000000003954.
     PubMed     Abstract available
     
     
     
398. MAZZITELLI M, Cozzolino C, Gasparini G, Chiaro E, et al
     Weight excess and obesity are associated with binge eating behaviours in people with HIV.
     AIDS. 2024 Jun 10. doi: 10.1097/QAD.0000000000003953.
     PubMed     Abstract available
     
     
     
399. DRECHSLER H, Ayers C, Oboho I, Enwerem N, et al
     Choice of antiretroviral therapy has low impact on weight gain.
     AIDS. 2024 Jun 3. doi: 10.1097/QAD.0000000000003950.
     PubMed     Abstract available
     
     
     
400. KUROSAWA S, Yoshimura Y, Takada Y, Yokota T, et al
     A predictive model for HIV-related lymphoma: a case series and literature review in Japan.
     AIDS. 2024 Jun 3. doi: 10.1097/QAD.0000000000003949.
     PubMed     Abstract available
     
     
     
401. ALIBUDBUD R
     Navigating the intersection: minority stress, mental health, and HIV care in the Philippines.
     AIDS. 2024;38:1097-1099.
     PubMed    
     
     
     
402. LEMOINE S, Bobo M, Hocqueloux L, Legac E, et al
     Dolutegravir-induced severe sideroblastic anemia.
     AIDS. 2024;38:1095-1097.
     PubMed    
     
     
     
403. HARRINGTON J, McCrary AW, Nguyen M, Nyandiko W, et al
     Proteomics discovery in children and young adults with HIV identifies fibrosis, inflammatory, and immune biomarkers associated with myocardial impairment.
     AIDS. 2024;38:1090-1093.
     PubMed     Abstract available
     
     
     
404. RAIFORD JL, Tie Y, Yuan XA, Byrd KK, et al
     Progress towards achieving national goals for improved quality of life among cis-gender Black women with HIV.
     AIDS. 2024;38:1087-1090.
     PubMed     Abstract available
     
     
     
405. MEYER L, Schim van der Loeff MF
     Sexually transmitted infections in the preexposure prophylaxis era.
     AIDS. 2024;38:1085-1086.
     PubMed    
     
     
     
406. VANCE DE, Brew BJ
     Plasma neurofilament light chain protein predicts greater brain-age gap, cognition, and cardiovascular risk in people with HIV.
     AIDS. 2024;38:1081-1083.
     PubMed    
     
     
     
407. GOYAL R, Hotchkiss J, Gilman B, Klein PW, et al
     The health equity implications of the Health Resources and Services Administration's Ryan White HIV/AIDS Program.
     AIDS. 2024;38:1025-1032.
     PubMed     Abstract available
     
     
     May 2024
408. WASILWA A, Amadi E, Ramadhani HO, Lascko T, et al
     Impact of enhanced adherence counselling on viral re-suppression among adolescents and young persons with persistent viremia.
     AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003945.
     PubMed     Abstract available
     
     
     
409. ZHANG M, Dai G, Smith DL, Zacco E, et al
     Interferon signaling pathways are upregulated in people with hiv with abnormal pulmonary diffusing capacity (DLCO).
     AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003946.
     PubMed     Abstract available
     
     
     
410. MCCABE L, Burns JE, Latifoltojar A, Post FA, et al
     MAVMET trial: maraviroc and/or metformin for metabolic dysfunction-associated fatty liver disease(MAFLD) in adults with suppressed HIV.
     AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003947.
     PubMed     Abstract available
     
     
     
411. CHITLE P, Sheira LA, Katabaro E, Winters S, et al
     The Impact of Financial Incentives on Mental Health among Adults in HIV Care in Lake Zone, Tanzania: A Two-Arm Randomized Controlled Trial.
     AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003948.
     PubMed     Abstract available
     
     
     
412. ZHAO J, Zhou X, Qiu Y, Jia R, et al
     Characterization of the gut butyrate-producing bacteria and lipid metabolism in African green monkey as a natural host of SIV infection.
     AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003944.
     PubMed     Abstract available
     
     
     
413. NJUGUNA C, Long L, Mistri P, Chetty-Makkan C, et al
     A randomised trial of "Fresh Start" text messaging to improve return to care in people living with HIV who missed appointments in South Africa.
     AIDS. 2024 May 29. doi: 10.1097/QAD.0000000000003939.
     PubMed     Abstract available
     
     
     
414. WAGNER TA, Tierney C, Huang S, Nichols S, et al
     Prevalence of detectable HIV-DNA and -RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy.
     AIDS. 2024 May 29. doi: 10.1097/QAD.0000000000003937.
     PubMed     Abstract available
     
     
     
415. SMITH AC, Goulet JL, Vlahov D, Justice AC, et al
     Self-injurious unnatural death among Veterans with HIV: a nested case-control study.
     AIDS. 2024 May 29. doi: 10.1097/QAD.0000000000003940.
     PubMed     Abstract available
     
     
     
416. JONGKEES MJ, Tan NH, Geers D, de Vries RD, et al
     Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.
     AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003933.
     PubMed     Abstract available
     
     
     
417. KAMITANI E, Mizuno Y, Khalil GM, Viguerie A, et al
     Improving HIV Pre-exposure Prophylaxis Uptake with Artificial Intelligence and Automation: A Systematic Review.
     AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003935.
     PubMed     Abstract available
     
     
     
418. GOLDBERG RL, Peterson TE, Haberlen SA, Witt MD, et al
     Associations between epicardial, visceral and subcutaneous adipose tissue with diastolic function in men with and without HIV.
     AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003936.
     PubMed     Abstract available
     
     
     
419. GUIGUES A, Gimenez S, Mettling C, Maurel D, et al
     The EBI2 receptor is coexpressed with CCR5 in CD4+ T cells and boosts HIV-1 R5 replication.
     AIDS. 2024 May 21. doi: 10.1097/QAD.0000000000003931.
     PubMed     Abstract available
     
     
     
420. CHANDASANA H, Hayes S, Buchanan AM, Brothers C, et al
     Bridging dolutegravir clinical viral response across doses and formulations using model-based exposure-response analysis in pediatrics.
     AIDS. 2024 May 20. doi: 10.1097/QAD.0000000000003929.
     PubMed     Abstract available
     
     
     
421. WEISER SD, Sheira LA, Weke E, Zakaras JM, et al
     An agricultural livelihood intervention is associated with reduced HIV stigma among people living with HIV.
     AIDS. 2024 May 16. doi: 10.1097/QAD.0000000000003928.
     PubMed     Abstract available
     
     
     
422. MATTHEWS LT, Jaggernath M, Kriel Y, Smith PM, et al
     Oral PrEP uptake, adherence, and persistence during periconception periods among women in South Africa: an intervention study.
     AIDS. 2024 May 15. doi: 10.1097/QAD.0000000000003925.
     PubMed     Abstract available
     
     
     
423. KELLY NK, Ranapurwala SI, Pence BW, Hightow-Weidman LB, et al
     The relationship between anti-LGBTQ+ legislation and HIV prevention among sexual and gender minoritized youth.
     AIDS. 2024 May 14. doi: 10.1097/QAD.0000000000003926.
     PubMed     Abstract available
     
     
     
424. XIA Q, Edelstein ZR, Katz B, Bertolino D, et al
     Impact of HIV pre-exposure prophylaxis prescriptions on HIV diagnoses in New York city.
     AIDS. 2024 May 14. doi: 10.1097/QAD.0000000000003927.
     PubMed     Abstract available
     
     
     
425. TRICKEY A, Zhang L, Rentsch CT, Pantazis N, et al
     Care interruptions and mortality among adults in Europe and North America: a collaborative analysis of cohort studies.
     AIDS. 2024 May 8. doi: 10.1097/QAD.0000000000003924.
     PubMed     Abstract available
     
     
     
426. BAI F, Bono V, Borghi L, Bonazza F, et al
     Association between tight junction proteins and cognitive performance in untreated Persons living with HIV (PLWH).
     AIDS. 2024 May 3. doi: 10.1097/QAD.0000000000003923.
     PubMed     Abstract available
     
     
     
427. 
     Sex differences in incident atherosclerotic cardiovascular disease events among women and men with HIV: Erratum.
     AIDS. 2024;38:935.
     PubMed    
     
     
     
428. BLOT-COSSARD A, Merad Y, Bachelard A, Lebreton C, et al
     Epidemiology and characteristics of Paget's disease of bone in a French nationwide HIV cohort.
     AIDS. 2024;38:929-931.
     PubMed     Abstract available
     
     
     
429. BARR EA
     Vespers: A nursing origin story set in the dawn of the HIV pandemic.
     AIDS. 2024;38:925-927.
     PubMed    
     
     
     
430. FEENEY ER, Boix V, Hsue PY
     Chronotropic incompetence in HIV infection.
     AIDS. 2024;38:921-923.
     PubMed    
     
     
     
431. ABDEL-HAMEED EA, Overton ET
     What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?
     AIDS. 2024;38:917-919.
     PubMed    
     
     
     
432. GOTTERT A, Malone S, Pulerwitz J
     The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa.
     AIDS. 2024;38:913-915.
     PubMed    
     
     
     
433. OURSLER KK, Briggs BC, Lozano AJ, Harris NM, et al
     Association of chronotropic incompetence with reduced cardiorespiratory fitness in older adults with HIV.
     AIDS. 2024;38:825-833.
     PubMed     Abstract available
     
     
     
434. LI N, Zheng HY, He WQ, He XY, et al
     Treatment outcomes amongst older people with HIV infection receiving antiretroviral therapy.
     AIDS. 2024;38:803-812.
     PubMed     Abstract available
     
     
     
435. JIANG J, Wang L, Li Q, Wang Y, et al
     HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood-retinal barrier.
     AIDS. 2024;38:779-789.
     PubMed     Abstract available
     
     
     
436. SALTO JN, Volkow P, Herrera-Goepfert R, Lopez-Garcia AI, et al
     Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS.
     AIDS. 2024;38:933-934.
     PubMed    
     
     
     April 2024
437. BRICKMAN CE, Agnello M, Imam N, Camejo P, et al
     Distinct anal microbiome is correlated with anal cancer precursors in men who have sex with men living with HIV.
     AIDS. 2024 Apr 30. doi: 10.1097/QAD.0000000000003920.
     PubMed     Abstract available
     
     
     
438. DERSEH NM, Agimas MC, Tesfie TK
     Risk score prediction for bacteriologically confirmed tuberculosis among HIV-infected adults on antiretroviral therapy in Ethiopia: prognostic model development.
     AIDS. 2024 Apr 25. doi: 10.1097/QAD.0000000000003917.
     PubMed     Abstract available
     
     
     
439. FILIP I
     Liver health matters: targeting modifiable factors to reduce the risk of advanced liver disease in people with HIV.
     AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003915.
     PubMed    
     
     
     
440. SAURA-LAZARO A, Augusto O, Fernandez-Luis S, Lopez-Varela E, et al
     HIV care retention in three multi-month ART dispensing: a retrospective cohort study in Mozambique.
     AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003913.
     PubMed     Abstract available
     
     
     
441. ZHAO J, Dong Y, Clark E, Garcia JM, et al
     Risk and predictors of penile cancer in US Veterans with HIV.
     AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003914.
     PubMed     Abstract available
     
     
     
442. KADIYALA GN, Telwatte S, Wedrychowski A, Janssens J, et al
     Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small molecules.
     AIDS. 2024 Apr 16. doi: 10.1097/QAD.0000000000003908.
     PubMed     Abstract available
     
     
     
443. MOAR P, Linn K, Premeaux TA, Bowler S, et al
     Plasma Galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV.
     AIDS. 2024 Apr 12. doi: 10.1097/QAD.0000000000003907.
     PubMed     Abstract available
     
     
     
444. FLORES JM, Moline T, Regan SD, Chen YT, et al
     Neighborhood violent crime exposure is associated with PrEP non-use among black sexually minoritized men and transgender women: A GPS Study.
     AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003906.
     PubMed     Abstract available
     
     
     
445. JANG Y, Kim T, Choi Y, Ahn KH, et al
     Association between obesity and cancer risk in HIV-infected Asians.
     AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003904.
     PubMed     Abstract available
     
     
     
446. OOSTERHOF P, Van Luin M, Brinkman K, Burger DM, et al
     Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen.
     AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003905.
     PubMed     Abstract available
     
     
     
447. GUARALDI G, Milic J, Renzetti S, Motta F, et al
     The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV.
     AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003903.
     PubMed     Abstract available
     
     
     
448. SABERIAN C, Lurain K, Hill LK, Marshall V, et al
     Kaposi sarcoma herpesvirus viral load in bronchoalveolar lavage as a diagnostic marker for pulmonary Kaposi sarcoma.
     AIDS. 2024 Apr 2. doi: 10.1097/QAD.0000000000003897.
     PubMed     Abstract available
     
     
     
449. 
     Prevalence and incidence of stroke among people with HIV: Erratum.
     AIDS. 2024;38:777.
     PubMed    
     
     
     
450. DE COCK KM, El-Sadr WM
     Authors' response to comment on 'Invisible, but not absent'.
     AIDS. 2024;38:774-775.
     PubMed    
     
     
     
451. AMON JJ
     To end AIDS, human rights must remain at the center of the HIV response.
     AIDS. 2024;38:773-774.
     PubMed    
     
     
     
452. FRESSE A, Massy N, Fournier D, Pinel S, et al
     Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemic.
     AIDS. 2024;38:768-771.
     PubMed     Abstract available
     
     
     
453. FRASER D, Holt M, Ong JJ, Bourne C, et al
     A proposal for a simplified measure of HIV preexposure prophylaxis prevention-effective adherence in self-report questionnaires.
     AIDS. 2024;38:765-767.
     PubMed     Abstract available
     
     
     
454. GONZALEZ-SCARANO F, Napravnik S, Vance DE
     Frailty and HIV-associated neurocognitive disorder are only modestly associated.
     AIDS. 2024;38:757-759.
     PubMed    
     
     
     
455. GOODREAU SM, Wohlfeiler DA, Bertrand T
     Bringing back condoms.
     AIDS. 2024;38:761-763.
     PubMed    
     
     
     
456. WILKINSON L, Grimsrud A
     Enabling effective differentiated service delivery transitions for people on antiretroviral treatment.
     AIDS. 2024;38:615-622.
     PubMed    
     
     
     March 2024
457. DIRAJLAL-FARGO S, Yu W, Jacobson DL, Mirza A, et al
     Gut permeability is associated with lower insulin sensitivity in youth living with perinatally-acquired HIV.
     AIDS. 2024 Mar 28. doi: 10.1097/QAD.0000000000003896.
     PubMed     Abstract available
     
     
     
458. SULLIVAN EV, Zahr NM, Zhao Q, Pohl KM, et al
     Contributions of cerebral white matter hyperintensities, age, and pedal perception to postural sway in people living with HIV.
     AIDS. 2024 Mar 27. doi: 10.1097/QAD.0000000000003894.
     PubMed     Abstract available
     
     
     
459. SCHNURE MC, Kasaie P, Dowdy DW, Genberg BL, et al
     Forecasting the effect of HIV-targeted interventions on the age distribution of people living with HIV: a case study from Kenya.
     AIDS. 2024 Mar 27. doi: 10.1097/QAD.0000000000003895.
     PubMed     Abstract available
     
     
     
460. GIANELLA S, Anderson C, Chaillon A, Wells A, et al
     Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy.
     AIDS. 2024 Mar 25. doi: 10.1097/QAD.0000000000003882.
     PubMed     Abstract available
     
     
     
461. WIJSTMA ES, Jongen VW, Boyd A, van den Elshout M, et al
     Concordance between daily diary reported PrEP intake and intraerythrocytic tenofovir diphosphate (TFV-DP) in the Amsterdam PrEP demonstration project.
     AIDS. 2024 Mar 21. doi: 10.1097/QAD.0000000000003889.
     PubMed     Abstract available
     
     
     
462. KEMP CG, Pence BW, Velloza J, Concepcion T, et al
     Cumulative exposure to depressive symptoms and all-cause mortality among adults living with HIV in Kenya, Nigeria, Tanzania, and Uganda.
     AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003891.
     PubMed     Abstract available
     
     
     
463. MIGISHA R, Chen G, Muyindike WR, Aung TN, et al
     Regional variation in weight change after the transition to dolutegravir: a prospective cohort study in Uganda and South Africa.
     AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003888.
     PubMed     Abstract available
     
     
     
464. CHOLLI PA, Buchacz KM, Harris NS, Crim SM, et al
     Self-rated Health and HIV Outcomes Among Adults with Diagnosed HIV - Medical Monitoring Project, United States, 2020-21.
     AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003890.
     PubMed     Abstract available
     
     
     
465. HAW NJL, Lesko CR, Ng DK, Lam J, et al
     Incidence of non-AIDS defining comorbidities among young adults with perinatally-acquired HIV in North America, 2000-2019.
     AIDS. 2024 Mar 19. doi: 10.1097/QAD.0000000000003892.
     PubMed     Abstract available
     
     
     
466. HU FH, Tang XL, Ge MW, Jia YJ, et al
     Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis.
     AIDS. 2024 Mar 18. doi: 10.1097/QAD.0000000000003886.
     PubMed     Abstract available
     
     
     
467. HIMELHOCH SS, Shuter J
     Authors' response to 'Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment'.
     AIDS. 2024;38:614.
     PubMed    
     
     
     
468. DAUNGSUPAWONG H, Wiwanitkit V
     Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment.
     AIDS. 2024;38:613.
     PubMed    
     
     
     
469. DICKSON S, James K
     Trends in HIV preexposure prophylaxis utilization and spending among individuals with commercial insurance.
     AIDS. 2024;38:610-612.
     PubMed     Abstract available
     
     
     
470. VANDERVEEN LA, Selzer L, Moldt B, Parvangada A, et al
     HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection.
     AIDS. 2024;38:607-610.
     PubMed     Abstract available
     
     
     
471. LEE D, Capeau J
     Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?
     AIDS. 2024;38:603-605.
     PubMed    
     
     
     
472. ZACCARELLI M
     Reassessing the emphasis on limited options in antiretroviral treatment.
     AIDS. 2024;38:599-601.
     PubMed    
     
     
     
473. WINSTON A, Price P
     Could humoral immune responses to herpesviruses be a pathogenic driver of cognitive disorders in persons with HIV?
     AIDS. 2024;38:597-598.
     PubMed    
     
     
     
474. MASCOLO S, Romanelli A
     A new frontier in HIV care: the predictive power of renal biomarkers on heart health.
     AIDS. 2024;38:595-596.
     PubMed    
     
     
     
475. COLBRUNN DK, Jacks C, Curry SR, Gebregziabher M, et al
     Outcomes of discordant HIV screening test results at a southern academic medical center.
     AIDS. 2024 Mar 14. doi: 10.1097/QAD.0000000000003884.
     PubMed     Abstract available
     
     
     
476. CROWELL TA, Ritz J, Zheng L, Naqvi A, et al
     Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial.
     AIDS. 2024 Mar 14. doi: 10.1097/QAD.0000000000003881.
     PubMed     Abstract available
     
     
     
477. FILIP I
     Changing costs of pre-exposure prophylaxis may undermine efforts to curb HIV infection rates.
     AIDS. 2024 Mar 12. doi: 10.1097/QAD.0000000000003883.
     PubMed    
     
     
     
478. DADABHAI S, Chou VB, Pinilla M, Chinula L, et al
     Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial.
     AIDS. 2024 Mar 4. doi: 10.1097/QAD.0000000000003878.
     PubMed     Abstract available
     
     
     February 2024
479. SHIVAKOTI R, Giganti MJ, Lederman MM, Ketchum R, et al
     Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery.
     AIDS. 2024 Feb 26. doi: 10.1097/QAD.0000000000003877.
     PubMed     Abstract available
     
     
     
480. WILSON IB, Cole MB, Lee Y, Shireman TI, et al
     The relationship of age and comorbid conditions to hospital and nursing home days in Medicaid recipients with HIV.
     AIDS. 2024 Feb 22. doi: 10.1097/QAD.0000000000003870.
     PubMed     Abstract available
     
     
     
481. WISEMAN RL, Bigos KL, Dastgheyb RM, Barker PB, et al
     Brain N-acetyl-aspartyl-glutamate (NAAG) is associated with cognitive function in older virally-suppressed people with HIV.
     AIDS. 2024 Feb 22. doi: 10.1097/QAD.0000000000003871.
     PubMed     Abstract available
     
     
     
482. PATEL D, Beer L, Yuan X, Tie Y, et al
     Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men.
     AIDS. 2024 Feb 8. doi: 10.1097/QAD.0000000000003860.
     PubMed     Abstract available
     
     
     January 2024
483. GEORGIADIS N, Papamichail D, Lytras T, Halkitis PN, et al
     The impact of HIV pre-exposure prophylaxis on bacterial sexually transmitted infection occurrence in MSM: A Systematic Review and Meta-analysis.
     AIDS. 2024 Jan 12. doi: 10.1097/QAD.0000000000003837.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.